document type sequence filename description text html head head body lang align right style margin text align right font size face time roman style font size font weight bold exhibit nbsp font align right style margin text align right font size face time roman style font size nbsp font align right style margin text align right font size face time roman style font size font weight bold confidential treatment material font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold confidential treatment requested information which confidential treatment been requested omitted noted with asterisk unredacted version this document been filed separately with security exchange commission commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold license development commercialization agreement font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold between font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold agenus font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold antibody font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold incyte europe sarl font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold incyte corporation solely purpose section nbsp font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font style margin font size face time roman style font size nbsp font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold license development commercialization agreement font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size this license development commercialization agreement agreement entered into january nbsp execution date between agenus delaware corporation having principal office forbes road lexington massachusetts agenus wholly owned subsidiary antibody stock corporation organized under switzerland with office hochbergerstrasse basel switzerland together with agenus other than with respect section nbsp agenus incyte europe sarl swiss limited liability company soci responsabilit limit having principal office cours rive geneva switzerland incyte solely purpose section nbsp nbsp incyte corporation delaware corporation having principal office augustine wilmington delaware parent agenus incyte referred this agreement individually party collectively party font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold recital font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size whereas agenus certain capability technology know useful discovery antibody including proprietary technology platform known retrocyte display technology font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size whereas agenus engaged number research development program that have arisen technology font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size whereas nbsp incyte engaged development commercialization pharmaceutical biological product human disease primarily field hematology oncology font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size whereas agenus incyte interested forming alliance whose goal discover develop commercialize robust portfolio product address hematologic oncologic disease condition font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size therefore consideration respective representation warranty covenant agreement contained herein other valuable consideration receipt sufficiency which hereby acknowledged party agree follows font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp definition font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size when used this agreement each following term shall have meaning forth this article nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size accounting standard with respect party mean that such party shall maintain record book account accordance with nbsp generally accepted accounting principle nbsp extent applicable nbsp international financial reporting standard each case nbsp consistently maintained font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size affiliate mean person entity which directly indirectly control controlled under common control with such person purpose this font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font style margin font size face time roman style font size nbsp font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size definition control refers following nbsp direct indirect ownership more voting security entitled vote election director case corporation more equity interest with power direct management case other type legal entity nbsp status general partner partnership nbsp other arrangement where entity posse directly indirectly power direct management policy another entity whether through ownership voting security contract otherwise font font size style font size party acknowledge that case certain entity organized under certain country outside united state maximum percentage ownership permitted foreign investor than that such case such lower percentage shall substituted preceding sentence provided that such foreign investor power direct management policy such entity font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus mean agenus know agenus patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus know mean know other than agenus platform know that nbsp controlled agenus subject section nbsp affiliate execution date during term nbsp necessary useful develop manufacture commercialize licensed antibody product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus platform know mean know controlled agenus subject section nbsp affiliate execution date during term that relates retrocyte display technology font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus platform patent right mean patent right controlled agenus subject section nbsp affiliate extent covering nbsp retrocyte display technology nbsp vaccine including prophage series nbsp vaccine adjuvant including stimulon adjuvant heat shock protein technology each case controlled agenus execution date during term font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus platform mean agenus platform know agenus platform patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus patent right mean patent right other than agenus platform patent right that nbsp controlled agenus subject section nbsp affiliate execution date during term nbsp nbsp cover licensed antibody product therapeutic preparation containing licensed antibody product nbsp otherwise necessary useful develop manufacture commercialize licensed antibody product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size allowable expense mean with respect profit share product each calendar quarter cost pocket cost incurred party their affiliate specific development manufacture commercialization such profit share product field territory during applicable calendar quarter including such cost pocket cost which nbsp development cost subject section nbsp nbsp manufacturing cost nbsp commercialization cost subject section font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size nbsp distribution cost nbsp regulatory cost nbsp patent trademark cost nbsp third party cost nbsp product liability cost nbsp medical affair cost allowable expense shall exclude case cost general corporate overhead administrative personnel clarity milestone payment made agenus affiliate pursuant section nbsp nbsp hereof shall allowable expense font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size antibody mean more molecule more gene encoding such molecule which comprise consist more immunoglobulin domain fragment nbsp thereof that specifically bind nbsp more target font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size assumed project mean discovery project added program pursuant section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size assumed project antibody mean antibody arising assumed project font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size biosimilar product mean with respect product biological product that nbsp nbsp biosimilar such product based upon data derived from nbsp analytical study that demonstrate that such biological product highly similar such product nbsp animal study nbsp more clinical study that sufficient demonstrate safety purity potency more indication which such product been approved nbsp utilizes same mechanism action such product nbsp nbsp nbsp united state similar interchangeable with respect such product evaluated nbsp outside united state similar comparable interchangeable bioequivalent biosimilar such product determined applicable regulatory authority nbsp authorized generic version such product where authorized generic version mean biological product that sold under filed incyte affiliate sublicensee such product product licensed produced incyte affiliate will constitute biosimilar product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size mean with respect product biologics license application defined public health service amended regulation promulgated thereunder counterpart foregoing supplement amendment that filed with respect foregoing font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size bullpen target mean target that designated during discovery period source potential discovery project proposed inclusion program pursuant section nbsp consist minimum maximum such target time font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size business mean other than saturday sunday federal holiday york york font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size calendar quarter mean calendar quarter ending last march june september nbsp december font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size calendar year mean period time commencing january nbsp ending following december nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size change control mean with respect party event which nbsp third party then beneficially owning more than voting power outstanding security such party acquires otherwise becomes beneficial owner security such party representing more than voting power then outstanding security such party with respect election director nbsp such party consummates merger consolidation similar transaction with third party where voting security such party outstanding immediately preceding such transaction represent than voting power such party surviving entity case immediately following such transaction nbsp such party sell substantially asset relating this agreement third party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size clinical trial mean phase clinical trial phase clinical trial phase clinical trial phase clinical trial pivotal clinical trial combination nbsp foregoing study font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size developed product mean royalty bearing product which agenus exercised development option described section nbsp paid reasonably undisputed development quarterly payment unless until agenus exercise termination right with respect such royalty bearing product pursuant section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size combination product mean with respect country royalty bearing product that received regulatory approval such country used administered with incyte product treat patient field font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size commercialization commercialize mean activity directed product planning activity obtaining pricing reimbursement approval marketing promoting distributing importing offering sell selling product including establishing price such product whether regulatory approval such product been obtained including related importation commercial manufacturing font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size commercialization cost mean profit share product profit share product basis cost pocket cost incurred incyte affiliate territory extent agenus exercise promotion option profit share product pursuant section nbsp party enter into promotion agreement agenus united state accordance with promotion agreement commercializing relevant profit share product field accordance with this agreement applicable commercialization plan subject section nbsp including such cost pocket cost which nbsp indirect selling expense nbsp includable sale marketing operation cost nbsp includable sale force cost nbsp marketing education expense each case determined from book record incyte affiliate applicable agenus each case maintained accordance with accounting standard font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size commercially reasonable effort party mean with respect objective reasonable diligent good faith effort such party including effort affiliate permitted sublicensees type accomplish such objective similarly situated with respect size stage development asset biopharmaceutical company would normally accomplish similar objective under similar circumstance being understood agreed that with respect effort expended relation product including implementation development manufacturing commercialization strategy such effort shall substantially equivalent those effort resource that similarly situated biopharmaceutical company would typically devote internally discovered compound product which compound product similar stage development product life similar market economic potential product similar stage development product life taking into account risk development commercial potential product proprietary position other relevant factor font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size completion mean with respect product clinical trial last dosing human with relevant product such clinical trial font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size confidential information mean subject section nbsp nbsp confidential proprietary information relating licensed antibody product nbsp other confidential proprietary document technology know other information whether patentable actually disclosed party other party pursuant this agreement prior confidentiality agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size control controlled mean with respect nbsp material document item information method data other know nbsp patent right other intellectual property right possession party subject section nbsp affiliate whether ownership license other than license granted under this agreement ability grant other party access license sublicense provided herein without requiring consent third party violating term agreement other arrangement with third party each case execution date same acquired created after execution date date acquired created relevant party affiliate provided however that such party subject section nbsp affiliate later gain ability grant such access license sublicense such material document item information method data other know nbsp patent right other intellectual property right without requiring such consent violating such term control shall deemed exist thereafter font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size converted product mean profit share product which agenus elected cease sharing profit loss described section nbsp clarity converted product shall deemed royalty bearing product under this agreement from after date such profit share product becomes converted product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size promotion mean with respect profit share product joint detailing effort with respect such profit share product united state further described font font size style font size promotion font font size style font size agreement font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size cover covering covered with respect product technology process method mean that control license granted person under valid claim included patent right under which such license granted development manufacture commercialization other such product practice such technology process method such person would infringe such valid claim case valid claim that issued would infringe such valid claim were issue font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size mean consumer price index urban wage earner clerical worker city average item published department labor bureau labor statistic successor equivalent index font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size detail mean nbsp face face discussion other direct communication detailing with physician other health care practitioner permitted under applicable prescribe product purpose promoting product such physician practitioner nbsp extent approved subcommittee established other interaction regarding promotion product with managed health care organization group purchasing organization pharmacy benefit manager large employer long term care organization insurer formulary government agency program medicare veteran health administration other federal state local agency similar organization font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size development develop mean with respect licensed antibody product antibody therapeutic preparation that contains antibody that interacts with discovery target discovery research preclinical clinical development activity including planning conduct clinical trial test method development stability testing toxicology formulation delivery system development cell line development process development clinical clinical supply manufacturing scale development clinical stage manufacturing quality assurance quality control procedure development performance with respect clinical material performance clinical trial statistical analysis report writing clinical study regulatory affair other regulatory approval activity including related importation medical affair activity nbsp when used verb develop mean engage development font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size development cost mean project project product product basis applicable cost pocket cost incurred either party affiliate developing such project product field territory accordance with this agreement consistent with applicable development plan including such cost pocket cost which nbsp explicitly included budget included applicable development plan subject section nbsp nbsp section nbsp nbsp manufacturing cost such product relevant product such project used development nbsp patent trademark cost patent right covering such product relevant product such project nbsp medical affair cost each case determined from book record applicable party affiliate maintained accordance with accounting standard development cost shall also include patent trademark cost pertaining bullpen target provided section nbsp font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size discovery period mean period beginning effective date ending december nbsp subject earlier termination provided below initial discovery period party mutually agree prior december nbsp extend discovery period additional period exceed three nbsp calendar year which case discovery period shall terminate such additional period notwithstanding foregoing agenus shall obligated terminate discovery period upon delivery written notice following consummation change control incyte provided that nbsp such notice termination must provided within three nbsp month following consummation such change control nbsp such termination shall have effect project that have commenced prior provision such notice termination font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size discovery project mean antibody discovery research development project directed against bullpen target proposed inclusion program either party time during discovery period pursuant section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size distribution cost mean with respect profit share product cost pocket cost that specifically identifiable allocable distribution such profit share product third party including nbsp handling storage distribution transportation custom clearance container freight shipping sale excise value added similar custom tariff duty insurance including shipment from third party logistics service provider wholesaler nbsp customer service including order entry billing adjustment inquiry credit collection font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size mean united state department justice font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size effective date mean second font font size style font size position relative font font size style font size business immediately following clearance date font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size mean european medicine agency successor agency thereto font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size exchange mean security exchange amended font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size executive officer mean chief executive officer each agenus incyte senior executive officer agenus incyte designated such chief executive officer font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size mean united state food drug administration successor agency thereto font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size field mean antibody treatment control mitigation prevention cure indication human animal hematology field oncology field font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size first commercial sale mean with respect product first sale such product intended patient third party applicable nbsp incyte incyte font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size related party country following applicable regulatory approval other than applicable governmental price reimbursement approval such product such country nbsp avoidance doubt sale transfer product clinical trial other development purpose compassionate similar shall considered first commercial sale font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size force majeure event mean with respect party event occurrence condition state fact each case outside reasonable control such party which include government rule regulation order issued governmental authority officer department agency instrumentality thereof fire storm flood earthquake accident rebellion insurrection riot terrorism invasion that interfere with normal business operation such party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size mean united state federal trade commission font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size mean full time equivalent person year consisting total hour calendar year scientific technical commercial work applicable undertaken applicable party affiliate employee purpose clarity single individual work more than hour calendar year single calendar year shall treated nbsp regardless number hour worked font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size cost mean period product obtained multiplying nbsp actual total ftes portion thereof devoted development manufacturing commercialization activity pursuant this agreement nbsp applicable rate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size rate mean rate which prorated daily basis necessary subject annual adjustment each calendar year during term percentage increase decrease december nbsp each calendar year over level december nbsp prior calendar year with first such increase effective font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size generic competition mean with respect product country given calendar quarter that during such calendar quarter more biosimilar product commercially available such country such biosimilar product aggregate have market share aggregate market share such product biosimilar product based data provided international such data available such other reliable data source agreed party such agreement unreasonably withheld measured unit sale such country font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size gitr mean glucocorticoid induced tnfr related protein font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size gitr antibody mean antibody that interacts with gitr that controlled agenus subject section nbsp affiliate execution date during term arises gitr project font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size gitr project mean project conducted under this agreement directed development manufacture commercialization antibody that interact with gitr font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size hematology field mean hematologic indication defined subsection disease blood blood forming organ international classification disease ninth revision clinical modification provided that hematology field shall exclude indication forth schedule font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size mean hart scott rodino antitrust improvement amended rule nbsp regulation promulgated thereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size clearance mean earlier nbsp notification party from early termination applicable waiting period under with respect filing nbsp expiration applicable waiting period under with respect filing provided however that shall commence investigation mean second request otherwise clearance mean termination such investigation without action prevent party from implementing transaction contemplated this agreement with respect united state font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size clearance date mean earlier nbsp date which shall notify party early termination waiting period under with respect filing nbsp date which applicable waiting period under with respect filing expires provided however that shall commence investigation mean second request otherwise clearance date mean date which investigation opened shall have been terminated without action prevent party from implementing transaction contemplated this agreement with respect united state font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size filing mean filing party with their respective premerger notification report form with respect matter forth this agreement stock purchase agreement together with required documentary attachment thereto font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size includable sale marketing operation cost mean with respect profit share product cost incurred nbsp developing advertising promotional educational material including related training material program such profit share product nbsp related payer reimbursement service each specifically identifiable allocable such profit share product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size includable sale force cost mean with respect profit share product cost incurred field sale representative regional district manager specifically identifiable allocable selling such profit share product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incremental royalty mean with respect developed product which agenus exercise right under section nbsp nbsp converted product difference font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size dollar royalty actually paid agenus sale unit applicable product rate forth section nbsp nbsp those that would have otherwise been payable same unit product royalty rate forth section nbsp nbsp applied font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte mean incyte know incyte patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte know mean know that nbsp controlled incyte subject section nbsp affiliate execution date during term nbsp necessary useful develop manufacture commercialize licensed antibody product excluding incyte product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte patent right mean patent right that nbsp controlled incyte subject section nbsp affiliate execution date during term nbsp nbsp cover licensed antibody product excluding incyte product nbsp otherwise necessary useful develop manufacture commercialize licensed antibody product excluding incyte product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte product mean with respect royalty bearing product country product controlled incyte subject section nbsp affiliate that nbsp contains compound which enabling toxicology study have been initiated prior during term nbsp received regulatory approval such country that permit such product used administered with such royalty bearing product field font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte program know mean know that nbsp discovered made conceived solely employee others acting behalf nbsp incyte affiliate during connection with program nbsp necessary useful develop manufacture commercialize licensed antibody product clarity know relating solely incyte other invention shall constitute incyte program know font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte program patent right mean patent right claiming incyte program invention clarity patent right claiming incyte other invention shall constitute incyte program patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte related party mean incyte affiliate permitted third party licensee sublicensees incyte program right develop manufacture commercialize product field including third party that function distributor font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size mean investigational drug application filed with under similar united state application submission country group country permission conduct human clinical investigation font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size indication mean disease condition syndrome font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size indirect selling expense mean with respect profit share product pocket cost incurred that specifically identifiable allocable selling such profit share product operate maintain sale force that promotes such profit share product territory excluding corporate administrative overhead cost included includable sale force cost other internal cost including cost sale meeting consultant including territory alignment sale deployment consulting call reporting other third party monitoring tracking cost including third party data purchase educational grant fund charitable contribution related profit share product font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size initiation mean with respect product clinical trial first dosing such clinical trial first human with relevant product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size intellectual property right mean patent right trade secret trademark copyright other form proprietary industrial right pertaining invention know original work other form intellectual property font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size interact mean bind specifically with target event antibody bind specifically with more than target shall deemed interact with whichever such target bind with greatest affinity unless determines otherwise font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size invention mean patentable invention discovery improvement other technology patent right based thereon that discovered made conceived during connection with research development manufacture commercialization licensed antibody product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size know font font size style font size mean technical information which execution date time during term public domain including information comprising relating data material result invention improvement protocol formula process method composition article manufacture formulation discovery finding know trade secret kind including scientific preclinical clinical regulatory manufacturing marketing financial commercial information data regulatory approval filing therefor regulatory documentation sequence information vector host cell that include each case whether patented patentable written electronic other form known hereafter developed excluding such information publicly disclosed patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size mean lymphocyte activation gene font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size antibody mean antibody that interacts with that controlled agenus subject section nbsp affiliate execution date during term arises project font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size project mean project conducted under this agreement directed development manufacture commercialization antibody that interact with font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size mean statute rule regulation ordinance other pronouncement having effect federal national multinational state provincial county city other political subdivision including applicable nbsp good manufacturing practice good laboratory practice good clinical practice adverse event reporting requirement guidance from international conference harmonization other generally accepted convention other rule regulation requirement other applicable regulatory authority nbsp foreign corrupt practice amended comparable country nbsp export control font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size licensed antibody mean profit share antibody royalty bearing antibody font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size licr mean ludwig institute cancer research font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size licr agreement mean that certain license agreement dated december nbsp between licr amended accordance with this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size major country mean font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size manufacture manufacturing mean applicable activity operation associated with production manufacture supply receipt processing filling finishing inspection testing packaging labeling shipping warehousing storage handling product including cell line development process formulation development process validation stability release testing manufacturing scale clinical clinical commercial manufacture supply qualification validation third party contract manufacturer scale process equipment validation initial manufacturing license approval inspection analytical development product characterization quality assurance quality control development testing release packaging development final packaging labeling shipping configuration shipping study overseeing conduct foregoing font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size manufacturing cost mean with respect product cost pocket cost incurred either party their respective affiliate manufacturing such product accordance with this agreement consistent with applicable development plan applicable commercialization plan including nbsp extent that such product corresponding licensed antibody manufactured third party manufacturer pocket cost incurred party affiliate third party manufacturer manufacture supply including packaging labeling thereof determined accordance with book record such party affiliate maintained accordance with accounting standard nbsp extent that such product corresponding licensed antibody manufactured party affiliate direct material cost cost attributable manufacture such product corresponding licensed antibody excluding cost general corporate overhead administrative font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size personnel determined accordance with book record such party affiliate maintained accordance with accounting standard font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size marketing education expense mean with respect profit share product pocket cost excluding corporate administrative overhead internal cost that specifically identifiable allocable advertising promotion marketing such profit share product consistent with applicable commercialization plan related professional education field extent performed sale representative including such pocket cost nbsp promotional educational material nbsp reimbursement patient assistance program health outcome program nbsp development information data specifically identifiable national account managed care organization group purchasing organization such profit share product consistent with commercialization plan nbsp development competitive intelligence nbsp branding expense nbsp packaging labeling expense nbsp advertisement appearing journal newspaper magazine other medium including direct mail electronic medium viii nbsp external market research nbsp profit share product specific public relation program nbsp sale operation reimbursement service nbsp training program material provided however that such expense shall exclude indirect selling expense medical affair cost font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size medical affair activity mean with respect product activity designed ensure improve appropriate medical conduct medical education further research regarding such product territory including with respect such product nbsp conducting service based medical activity including providing input assistance with consultancy meeting recommending investigator clinical trial providing input design such trial other research related activity delivering promotional communication conduct promotional activity including presenting clinical trial data other scientific information nbsp grant support continuing medical education symposium third party research specifically related such product territory nbsp development publication dissemination publication relating such product relevant disease state territory nbsp medical information service provided response inquiry communicated sale representative received letter phone call email nbsp conducting advisory board meeting other consultant program nbsp support investigator initiated clinical trial nbsp managing relationship with cooperative group physician hospital network advocacy group nbsp establishing implementing risk evaluation mitigation strategy nbsp phase clinical trial font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size medical affair cost mean with respect product cost pocket cost incurred accordance with this agreement consistent with applicable development plan commercialization plan that specifically identifiable allocable medical affair activity with respect such product field font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size mhlw mean japanese ministry health labor welfare successor agency thereto font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size mskcc mean memorial sloan kettering cancer center font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size named target mean applicable gitr target which assumed project directed font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size sale mean with respect product gross amount invoiced incyte incyte related party sale other disposition such product with respect terminated product gross amount invoiced agenus affiliate licensee sublicensees sale other disposition such terminated product applicable third party otherwise directly indirectly paid earned incyte incyte related party with respect sale such product agenus affiliate sublicensees with respect sale such terminated product each case following font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size trade cash quantity discount already reflected amount invoiced extent related gross amount invoiced font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size allowance adjustment credited payable including credit spoiled damaged outdated recalled returned product terminated product extent related gross amount invoiced substantiated reasonable documentation font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size freight insurance other transportation charge incurred shipping such product terminated product third party extent identified such invoice third party extent included gross amount invoiced font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size amount repaid credited reason rejection defect recall return because chargebacks refund rebate including wholesaler inventory management retroactive price reduction commission discount billing error other allowance which effectively reduce selling price font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size tariff duty excise sale other including value added custom duty imposed such product terminated product each case extent invoiced customer otherwise included within gross amount invoiced font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size other similar customary deduction which accordance with applicable accounting standard font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size sale will include sale between among incyte incyte related party agenus affiliate sublicensees applicable provided however that resale third party shall included sale font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size sale shall calculated accordance with accounting standard nbsp case sale other disposal value such barter counter trade product terminated product part thereof other than length transaction exclusively cash sale shall calculated above value cash consideration received fair market price higher such product terminated product country sale disposal determined accordance with accounting standard donated product terminated product reasonable quantity will excluded from sale font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size north america mean united state america canada mexico their respective territory possession font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size oncology field mean oncology indication defined subsection neoplasm international classification disease ninth revision clinical modification including hematologic malignancy solid tumor myeloproliferative disease including myelofibrosis polycythemia rubra vera essential thrombocythemia listed font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size pocket cost mean with respect specified activity hereunder direct expense paid payable either party affiliate third party other than employee such party affiliate that specifically identifiable incurred conduct such activity product have been recorded accordance with accounting standard font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size mean member tumor necrosis factor superfamily receptor that otherwise known font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size antibody mean antibody that interacts with that controlled agenus subject section nbsp affiliate execution date during term arises project font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size project mean project conducted under this agreement directed development manufacture commercialization antibody that interact with font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size patent trademark cost mean with respect product cost pocket cost incurred either party affiliate connection with nbsp prosecution agenus patent right nbsp incyte program patent right joint patent right that cover such product field territory reasonably allocated such product field such patent right cover product other than product indication outside field nbsp conducting patentability landscape freedom operate analysis including preparing opinion invalidity infringement with respect invention patent right potential relevance such product nbsp when mutually agreed internal external patent counsel party with notice conducting opposition invalidation reexamination reissue post grant review inter partes review other similar administrative proceeding administrative appeal thereof litigation thereof with respect third party patent right potential relevance such product nbsp enforcing agenus patent right nbsp incyte program patent right joint patent right covering such product field territory accordance with this agreement nbsp defending third party infringement claim invalidity claim with respect agenus patent right nbsp incyte program patent right joint patent right covering such product field territory nbsp establishing maintaining enforcing product specific trademark territory patent trademark cost shall include foregoing activity they pertain bullpen target extent mutually agreed internal external patent counsel party with notice font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size patent right mean united state patent patent application provisional patent application utility model utility model application design patent registered industrial design design application application registration industrial design substitution divisionals continuation continuation part application continued prosecution application reissue reexamination extension thereof font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size patent term extension mean patent term extension under counterpart foregoing including supplemental protection certificate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size mean programmed cell death protein font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size antibody mean antibody that interacts with that controlled agenus subject section nbsp affiliate effective date arises internal discovery project conducted agenus subject section nbsp nbsp affiliate during period beginning effective date ending thereafter font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size permitted subcontractor mean affiliate third party which party subcontract portion activity allocated under development plan commercialization plan accordance with term this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size person mean natural person general limited partnership corporation limited liability company limited liability partnership firm association organization other legal entity font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size phase clinical trial mean study human which provides first introduction into human product conducted healthy volunteer patient obtain information product safety tolerability pharmacological activity pharmacokinetics more fully defined nbsp united state equivalent thereof font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size phase clinical trial mean study human safety dose ranging efficacy product which prospectively designed generate sufficient data successful commence pivotal clinical trial further defined nbsp united state equivalent thereof font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size phase clinical trial mean controlled study human efficacy safety product which prospectively designed demonstrate statistically whether such product effective safe particular indication manner sufficient file obtain regulatory approval market product further defined nbsp united state equivalent thereof font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size phase clinical trial mean human clinical trial which conducted product after regulatory approval product been obtained from appropriate regulatory authority includes nbsp trial conducted voluntarily enhancing marketing font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size scientific knowledge approved indication nbsp trial conducted after regulatory approval request requirement regulatory authority condition previously granted regulatory approval font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size pivotal clinical trial mean nbsp phase clinical trial that prospectively designed generate sufficient data successful file accelerated approval nbsp phase clinical trial font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size prior confidentiality agreement mean confidentiality agreement between incyte agenus dated nbsp amended august nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size product liability cost mean with respect product cost pocket cost incurred either party affiliate associated with nbsp recall such product field territory including cost investigation corrective action with respect thereto nbsp excess product liability cost extent forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size product product mean collectively profit share product royalty bearing product clarity product includes combination product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size profit loss mean profit share product profit share product basis with respect calendar quarter nbsp sale such profit share product field territory incyte incyte related party plus nbsp profit share product proceeds minus nbsp allowable expense extent such deduction have already otherwise been deducted determined from book record party their respective affiliate permitted subcontractor accordance with accounting standard purpose clarity understood that nbsp there shall double counting expense within definition profit loss nbsp profit loss shall calculated payable accordance with section nbsp even there sale prior first commercial sale font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size profit share antibody mean gitr antibody antibody assumed project antibody arising assumed project designated agenus profit share project pursuant section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size profit share product mean therapeutic preparation that contains more profit share antibody provided however that prior commencement development therapeutic preparation that contains both profit share antibody royalty bearing antibody party through shall discus good faith agree appropriate financial arrangement relating such therapeutic preparation which could include agreement upon allocation allowable expense profit loss between party with respect thereto font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size profit share project mean gitr project project each assumed project designated agenus profit share project pursuant section nbsp font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size profit share product proceeds mean with respect profit share product proceeds received incyte affiliate from third party with respect development manufacture commercialization such profit share product field territory including proceeds attributable grant license sublicense grant distribution right permitted sublicensees distributor under this agreement develop manufacture commercialize such profit share product right addition such right such profit share product granted such third party then reasonably allocated right granted such third party with respect such profit share product excluding font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size amount received incyte affiliate payment their actual reasonably allocated direct cost including cost pocket cost perform development manufacturing commercialization activity undertaken incyte affiliate collaboration with such third party with respect such profit share product extent such cost have been included allowable expense font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size amount received incyte affiliate from such third party purchase price incyte affiliate debt equity security except that amount which exceed fair market value such debt equity security shall excluded extent otherwise falling within this definition font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size those patent trademark cost paid incyte affiliate reimbursed such third party with respect such profit share product incurred with respect multiple profit share product other product then reasonably allocated relevant profit share product extent such cost have been included allowable expense font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size amount received incyte reimbursement cost borne solely incyte with respect third party claim which third party obligated indemnify incyte font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size program mean program develop manufacture commercialize product field territory under this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size program right mean right develop manufacture commercialize product pursuant this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size project mean collectively gitr project project project project assumed project font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size prosecution prosecute mean with respect particular patent right activity associated with preparation filing prosecution maintenance such patent right patent application nbsp derived from such patent right well examination reissue application patent term adjustment extension supplementary protection certificate like with respect that patent right together with conduct interference opposition invalidation reexamination reissue proceeding post grant review inter font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font style italic partes font font size style font size review derivation proceeding other similar administrative proceeding administrative appeal thereof with respect that patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size publication mean publication scientific journal abstract presented scientific audience subject confidentiality obligation presentation scientific conference including slide text oral other public presentation presented scientific audience subject confidentiality obligation other scientific presentation other oral written electronic disclosure directed scientific audience subject confidentiality obligation each case which pertains product licensed antibody product field font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size regulatory approval mean with respect product approval including applicable governmental price reimbursement approval license registration authorization federal national multinational state provincial local regulatory authority department bureau other governmental entity that necessary marketing sale such product country group country font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size regulatory authority mean with respect country regulatory authority regulatory authority such country with authority over testing manufacture storage importation promotion marketing pricing sale biological product such country font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size regulatory cost mean with respect product cost pocket cost incurred party affiliate associated with preparation filing inds blas maintenance regulatory approval such product field including such cost pocket cost which nbsp paid regulatory authority directly related inds blas regulatory approval such product field nbsp cost regulatory interaction with respect such product field nbsp cost establish maintain global safety database such product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size regulatory documentation mean with respect product inds blas other regulatory application submitted regulatory authority copy regulatory approval orphan drug designation fast track breakthrough similar designation regulatory material drug dossier master file including drug master file defined united state equivalent other report record regulatory correspondence other material relating regulatory approval such product required manufacture distribute sell such product including information that relates pharmacology toxicology chemistry manufacturing control data batch record safety efficacy safety database required maintained regulatory authority font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size regulatory exclusivity mean with respect product that third party prevented from legally developing manufacturing commercializing product that could compete with such product country either through data exclusivity right orphan drug designation such other right conferred regulatory authority such country other than through patent right font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size regulatory interaction mean nbsp regulatory action communication filing with submission regulatory authority with respect product nbsp interfacing corresponding meeting with regulatory authority with respect product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size retrocyte display technology mean nbsp patent right controlled agenus affiliate that cover know controlled agenus affiliate that relate discovery optimization antibody other molecule against target interest including patent right arising from application publication nbsp platform embodying component component step other portion foregoing nbsp retrocyte display improvement clarity excluding know that specific licensed antibody product nbsp patent right that cover licensed antibody product font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size retrocyte display improvement mean invention constituting improvement enhancement modification adaptation retrocyte display technology patent right covering such invention know that specific constitutes improvement enhancement modification adaptation retrocyte display technology font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size royalty bearing antibody mean antibody antibody assumed project antibody arising assumed project designated agenus royalty bearing project pursuant section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size royalty bearing product mean subject section nbsp therapeutic preparation that contains more royalty bearing antibody font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size royalty bearing project mean project project each assumed project designated agenus royalty bearing project pursuant section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size target mean protein corresponding sequence font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size territory mean entire world font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size third party mean person other than party affiliate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size third party cost mean with respect profit share product royalty license other payment applicable that nbsp reasonably allocable necessary useful development manufacture commercialization such product field territory nbsp incurred either party affiliate license intellectual property right from third party nbsp first licensed such party affiliate after effective date font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size mean cell immunoglobulin mucin font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size antibody mean antibody that interacts with that controlled agenus subject section nbsp affiliate execution date during term arises project font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size project mean project conducted under this agreement directed development manufacture commercialization antibody that interact with font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size vaccine mean immunogen administration which intended stimulate immune system result prevention amelioration therapy indication font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size valid claim mean nbsp claim issued patent that expired been abandoned been revoked held invalid unenforceable patent office court other governmental agency competent jurisdiction final appealable judgment judgment from which appeal taken within allowable time period nbsp claim within patent application that filed good faith which been abandoned finally disallowed without possibility appeal refiling such application provided that font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size voting stock mean security class series corporation limited liability company association other entity holder which ordinarily absence contingency entitled vote generally matter before shareholder member such corporation limited liability company association other entity including right vote election director member equivalent governing body font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold additional definition font font size style font size nbsp each following definition forth section this agreement indicated below font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse margin left width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold definition font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold section nbsp number font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font weight bold font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size introduction font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold abandoned commercialization font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold abandoned development font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold agreement font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size introduction font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold agenus font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size introduction font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold agenus indemnified party font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold agenus font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size introduction font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold authorized generic version font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold bankruptcy code font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold biosimilar notice font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold breaching party font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold development option font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold development quarterly payment font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold development royalty font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold commercialization plan font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold promotion agreement font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font table style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse margin left width width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold promotion option font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold development plan font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold disclosing party font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold discovery option font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold discovery target font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold excess product liability cost font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold execution date font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size introduction font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold expert font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size schedule font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold global safety database font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold incyte font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size introduction font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold incyte indemnified party font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold incyte other invention font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold incyte program invention font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold initial discovery period font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold insolvency proceeding font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold invalidity claim font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size schedule font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold joint invention font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold joint patent right font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold licensed infringement font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold loss font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold negotiation notice font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold negotiation period font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold breaching party font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold option period font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold option product font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold paragraph notice font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold parent font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size introduction font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold party party font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size introduction font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold payee font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold payment font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold payor font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold negotiation notice font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold negotiation period font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold territory font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold trigger period font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold project management team font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold recipient font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold rofn trigger period font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold royalty term font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold severed clause font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font table style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse margin left width width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold stock purchase agreement font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold subcommittee font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold term font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold terminated product font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold terminated project font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold third party infringement claim font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold triggering information font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold voting security font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold withhold font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold withholding font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font table align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp license font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold right granted agenus font font size style font size nbsp subject term this agreement applicable with respect relevant agenus retained right licr mskcc under licr agreement agenus hereby grant incyte during term exclusive royalty bearing transferable except accordance with section nbsp license sublicense applicable under agenus develop manufacture commercialize licensed antibody product territory field font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold right granted incyte font font size style font size subject term this agreement nbsp incyte hereby grant agenus font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size exclusive royalty free transferable except accordance with section nbsp license sublicense applicable under incyte solely extent necessary permit agenus affiliate exercise their respective right perform their respective obligation under this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size exclusive fully paid sublicensable license sublicense applicable under incyte program patent right incyte program know develop manufacture commercialize licensed antibody product excluding combination product territory outside field font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold sublicense right font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size each party shall have right grant sublicenses under license granted other party under section affiliate subject section applicable third party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte affiliate freely sublicense agenus third party directly indirectly through multiple tier except that sublicense under agenus nbsp licensed agenus licr pursuant licr agreement shall require prior written consent agenus such consent unreasonably withheld delayed conditioned font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size nbsp covering commercialization product field shall subject provision subsection nbsp below incyte shall provide agenus with copy such sublicense agreement within after execution thereof each sublicense agenus shall consistent with term condition this agreement applicable licr agreement forth section nbsp below incyte shall guarantee performance affiliate permitted sublicensees with respect sublicense granted pursuant this section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus freely sublicense right granted agenus under incyte program patent right incyte program know outside field third party subject provision section nbsp agenus shall provide incyte with copy such sublicense agreement within after execution thereof each sublicense incyte program patent right incyte program know outside field shall consistent with term condition this agreement agenus shall guarantee performance permitted sublicensees with respect sublicense granted pursuant this section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size event that incyte desire commence negotiation with third party other than permitted subcontractor third party distributor license sublicense portion incyte program right commercialize product field nbsp incyte shall promptly notify agenus intent enter into such transaction identifying specific product that will subject such transaction within after receipt such notification rofn trigger period agenus shall notify incyte writing either that nbsp agenus interested negotiating agreement with respect such program right negotiation notice nbsp agenus interest therefore waif right first negotiation with respect such program right agenus notifies incyte writing within such period that agenus desire negotiate agreement with respect such program right party shall negotiate good faith from date such notification negotiation period such longer period agreed between party regarding term pursuant which party would enter into transaction with respect such program right failure agenus give written notice interest lack interest negotiating such agreement within after receipt written notice from incyte described first sentence this section nbsp nbsp shall deemed constitute waiver agenus right first negotiation with respect such program right agenus provided negotiation notice within rofn trigger period incyte agenus unable reach agreement during negotiation period nbsp incyte offer program right applicable product third party provided however that font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold section nbsp font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size right license granted under pursuant section this agreement including right sublicense shall otherwise deemed purpose section nbsp nbsp title code bankruptcy code license right intellectual property defined section nbsp bankruptcy code party shall retain fully exercise their respective right election under bankruptcy code each party agrees that other party extent that licensee such right under this agreement shall retain fully exercise right font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size election under bankruptcy code that upon commencement bankruptcy proceeding against party under bankruptcy code other party shall entitled complete duplicate complete access such other party deems appropriate such intellectual property embodiment such intellectual property provided that such other party continues fulfill obligation specified herein full such intellectual property embodiment thereof shall promptly delivered other party nbsp upon such commencement bankruptcy proceeding upon written request therefor other party unless party subject such bankruptcy proceeding elect continue perform obligation under this agreement nbsp delivered under nbsp above upon rejection this agreement behalf party subject such bankruptcy proceeding upon written request therefor other party foregoing without prejudice right that either party have arising under bankruptcy code other applicable font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size nothing this section nbsp shall deemed admission that this agreement executory contract that this agreement obligation hereunder otherwise subject rejection disavowal bankruptcy liquidation reorganization receivership assignment benefit creditor administration insolvency similar proceeding circumstance insolvency proceeding party admission that upon such proceeding circumstance involving party upon such rejection disavowal party other party sublicensee thereof would lose able enforce benefit from right hereunder under applicable sublicense font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size each party agrees acknowledges licensor intellectual property under this agreement entering this agreement granting right respectively grant under this agreement effort protect valuable intellectual property relied particular skill business quality other party recipient such right such skill business quality include expected future innovation other party particular market segment addressed other party business each party further agrees acknowledges that upon occurrence insolvency proceeding this agreement type described section nbsp nbsp nbsp bankruptcy code under other applicable such reason font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold implied license right retained right font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold implied license right font font size style font size nbsp except expressly provided section nbsp elsewhere this agreement right agenus other patent right know agenus affiliate hereby retained agenus affiliate except expressly provided section nbsp elsewhere this agreement right incyte other patent right know incyte affiliate hereby retained incyte affiliate purpose clarity notwithstanding other provision this agreement license granted section nbsp give incyte right utilize exploit nbsp agenus licensed antibody product outside field nbsp retrocyte display technology retrocyte display improvement patent right know controlled agenus affiliate covering foregoing nbsp patent right know controlled agenus affiliate covering vaccine including font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size prophage series nbsp vaccine adjuvant including stimulon adjuvant heat shock protein technology font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold retained right font font size style font size notwithstanding exclusive license granted incyte pursuant section nbsp agenus retains right practice under agenus nbsp exercise right perform sublicense third party perform obligation under this agreement nbsp purpose outside field subject provision section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold licr agreement font font size style font size incyte acknowledges agrees that certain license hereunder subject following term condition licr agreement nbsp reporting record keeping obligation with respect sale product provided section licr agreement nbsp indemnification under section nbsp nbsp licr agreement nbsp obligation name provided section nbsp licr agreement event conflict inconsistency between applicable provision this agreement such provision licr agreement such provision licr agreement shall prevail with respect relevant agenus licensed agenus licr pursuant licr agreement except extent such inconsistency result from breach agenus section nbsp purpose clarity financial obligation agenus under licr agreement shall sole responsibility agenus font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold compete font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold font font size style font size neither agenus subject section nbsp affiliate shall develop manufacture commercialize outside field licensed antibody product that identified being developed manufactured commercialized under development plan commercialization plan hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold font font size style font size neither incyte subject section nbsp affiliate shall develop manufacture commercialize licensed antibody product outside field font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold font font size style font size neither party subject section nbsp affiliate shall independently with third party conduct development manufacture commercialize territory antibody that interacts with named target including clarity licensed antibody bullpen target therapeutic preparation containing such antibody field other than part program except nbsp prior written consent other party been obtained nbsp case party antibody that interacts with bullpen target that subject discovery project that other party declined include program assumed project pursuant section nbsp long such antibody interact with named target another bullpen target nbsp each party conduct preclinical other nonclinical research including screening comparative pharmacology using antibody obtained from third party owned third party order help advance position effort party program nbsp each party screen antibody purpose determining that such antibody interact with named target bullpen target clarity elect remove target from list bullpen target antibody that interacts with such bullpen target shall longer font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size subject this section nbsp nbsp only such antibody interact with named target another bullpen target font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size during period beginning effective date ending thereafter later expiration negotiation period neither incyte subject section nbsp affiliate shall independently with third party conduct development manufacture commercialize territory antibody that interacts with therapeutic preparation containing such antibody field except nbsp prior written consent agenus been obtained nbsp incyte screen antibody purpose determining that such antibody interact with font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size event either party affiliate acquires control control defined section nbsp third party activity such third party shall constitute breach this agreement provided that nbsp later than following consummation transaction which such party affiliate acquires control such third party acquiring party affiliate take appropriate action through presentation applicable product other party pursuant section nbsp divestiture asset otherwise cause such party come into compliance with term this agreement nbsp during such period acquiring party affiliate keep such acquired third party activity with respect antibody therapeutic preparation that would otherwise breach section nbsp nbsp separate from development manufacturing commercialization program licensed antibody product ensures that confidential information utilized such activity nbsp acquiring party continues meet other obligation hereunder font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size event that party undergoes change control then research development manufacture commercialization field territory antibody that interacts with named target bullpen target therapeutic preparation containing such antibody that date such change control being researched developed manufactured commercialized assignee acquirer such party person which immediately prior such change control affiliate such assignee acquirer shall constitute breach this agreement provided that nbsp such assignee acquirer affiliate keep such research development manufacturing commercialization program such other antibody product containing such antibody separate from development manufacture commercialization program licensed antibody product ensures that confidential information utilized such program nbsp acquired assigning party continues meet obligation hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold negotiation right font font size style font size event that agenus desire commence negotiation with third party with respect grant commercialization right field antibody north america european union territory time during period beginning effective date ending thereafter during such period agenus desire continue such negotiation which were begun after execution date before effective date agenus shall promptly notify incyte intent enter into such transaction within after receipt such notice trigger font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold period font font size style font size nbsp incyte shall notify agenus writing either that nbsp incyte interested negotiating agreement with respect such antibody field portion territory negotiation notice nbsp incyte interest therefore waif right first negotiation incyte notifies agenus writing within trigger period that incyte desire negotiate agreement party shall negotiate good faith from date such notification negotiation period such longer period agreed between party regarding term pursuant which party would enter into transaction with respect such antibody field territory failure incyte give written notice interest lack interest negotiating such agreement within trigger period portion territory shall deemed constitute waiver incyte right first negotiation incyte provided negotiation notice within trigger period incyte agenus unable reach agreement during negotiation period agenus offer antibody right field territory third party provided however that font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp governance font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold joint steering committee font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold establishment font font size style font size nbsp party shall establish joint steering committee within thirty after effective date that will have responsibility overall coordination oversight development manufacture commercialization licensed antibody product under this agreement nbsp soon practicable following effective date event more than thirty following effective date each party shall designate initial three nbsp representative nbsp each party representative substitute representative shall bound obligation confidentiality forth article nbsp representative from incyte shall chairperson provided however that following consummation change control incyte representative from agenus shall chairperson nbsp chairperson shall have greater authority than other representative shall responsible following activity nbsp calling meeting nbsp preparing issuing minute each such meeting within thirty thereafter nbsp ensuring that decision making delegated carried accordance with section nbsp nbsp preparing circulating agenda upcoming meeting provided that chairperson shall include agenda item proposed other party nbsp each party shall free change representative notice other party send substitute representative meeting provided however that each party shall ensure that time during existence representative appropriate term expertise seniority then current stage development commercialization product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold responsibility font font size style font size nbsp shall have responsibility nbsp nbsp overseeing initial transfer information designated activity between party relating development licensed antibody product nbsp providing general oversight over development licensed antibody product including periodic review approval development plan material update amendment modification thereto font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size review evaluation progress under development plan nbsp reviewing amending subject section nbsp approving development budget each project nbsp selecting indication development product field nbsp determining which party will responsible regulatory interaction with respect product nbsp reviewing regulatory approach filing strategy with respect seeking obtaining regulatory approval product field territory nbsp determining which party will responsible selecting monitoring manufacturing vendor otherwise being responsible manufacturing activity with respect product viii nbsp managing list bullpen target including adding removing target from such list nbsp discussing potential discovery project nbsp developing publication plan each project approving publication nbsp providing general oversight over commercialization product including periodic review approval commercialization plan profit share product material update amendment modification thereto nbsp reviewing amending subject section nbsp approving commercialization budget profit share product xiii nbsp performing such other function expressly forth this agreement appropriate further purpose this agreement mutually agreed upon party writing font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold project management team other subcommittee font font size style font size nbsp shall establish more project management team each project management team with such project management team being established each project unless otherwise agreed clarity instead determine that there should single project management team program different project management team early stage late stage development activity project other approach approved project management team shall have responsibility coordinating expediting controlling development product obtain regulatory approval each project management team will with respect applicable project unless otherwise agreed nbsp develop recommend update development plan including annual development budget nbsp facilitate flow information with respect development work being conducted each product territory nbsp discus cooperate regarding conduct such development work establish disband such other subcommittee deemed necessary each subcommittee each project management team subcommittee shall consist same number representative designated each party which number shall mutually agreed party nbsp avoidance doubt either party designate same representative serve multiple project management team subcommittee project management team subcommittee each party shall free change representative notice other send substitute representative project management team subcommittee meeting provided however that each party shall ensure that time during existence project management team subcommittee representative such project management team subcommittee appropriate term expertise seniority then current stage development applicable product field territory each party representative substitute representative shall bound obligation confidentiality forth article nbsp nbsp project management team subcommittee shall font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size have authority bind party hereunder each project management team subcommittee shall report decision shall made font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold committee meeting font font size style font size nbsp each project management team subcommittee shall each hold least nbsp meeting calendar quarter such time during such calendar quarter chairperson elect nbsp except where party fails appoint member member project management team subcommittee fails participate meeting project management team subcommittee pursuant section nbsp meeting project management team subcommittee respectively shall effective only least nbsp representative each party present participating nbsp each project management team subcommittee meet either nbsp person either party facility united state such location party otherwise agree nbsp audio video teleconference provided that than nbsp meeting during each calendar year shall conducted person nbsp other representative each party involved with relevant product attend meeting voting participant subject confidentiality provision forth article nbsp nbsp additional meeting project management team subcommittee also held with consent each party neither party shall unreasonably withhold consent hold such additional meeting required under this agreement nbsp each party shall responsible expense incurred connection with participating such meeting such expense shall development cost allowable expense hereunder font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold authority font font size style font size nbsp each project management team subcommittee shall have only power assigned expressly this article nbsp elsewhere this agreement shall have power amend modify waive compliance with this agreement nbsp furtherance thereof each party shall retain right power discretion granted under this agreement such right power discretion shall delegated vested project management team subcommittee unless such delegation vesting right expressly provided this agreement party expressly agree writing font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold decision font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold initial dispute resolution procedure font font size style font size nbsp subject provision this section nbsp action taken each project management team subcommittee shall taken only following unanimous vote with each party through representative having nbsp vote nbsp project management team subcommittee fails reach consensus matter before decision period excess thirty either party shall have right refer matter font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold final decision making font font size style font size fails reach unanimous agreement matter properly before accordance with this article nbsp decision period excess thirty representative appointed incyte shall have deciding vote provided however that after consummation change control incyte agenus shall have deciding vote with respect matter subject approval relating font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size profit share project nbsp party that have deciding vote shall have right appeal such decision executive officer resolution pursuant section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold limit decision making font font size style font size notwithstanding foregoing party shall exercise right finally resolve dispute pursuant section nbsp nbsp nbsp manner that expands such party right excuse such party from obligation specifically enumerated under this agreement nbsp manner that negates consent right other right specifically allocated other party under this agreement nbsp manner that imposes additional development cost allowable expense other party which would reimbursed hereunder resolving party except expressly provided section nbsp nbsp resolve dispute regarding whether milestone event forth herein been achieved nbsp designate undesignate target bullpen target nbsp determine whether antibody that bind specifically with more than target shall deemed interact with whichever such target bind with greatest affinity nbsp manner that would require party perform that reasonably belief inconsistent with approval order policy guideline regulatory authority font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold committee membership font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold appointment right font font size style font size nbsp appointment member project management team subcommittee right each party obligation shall deliverable referenced existing authoritative accounting literature nbsp each party shall free determine appoint member project management team subcommittee font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold consequence appointment font font size style font size nbsp party appoint member project management team subcommittee shall breach this agreement shall consideration required returned unless until such member appointed party that made requisite appointment unilaterally discharge role project management team subcommittee which member were appointed provided that neither party shall unilaterally discharge role project management team subcommittee permitted under this section nbsp nbsp unless other party appointed member within thirty after first party completed appointment member font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold future adjustment governance font font size style font size nbsp party time mutual written agreement create delete governance committee subcommittee make other modification governance structure contemplated this agreement order promote efficient operation program font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp development font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold conduct development activity font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold generally font font size style font size each party shall commercially reasonable effort develop obtain regulatory approval product field territory soon practicable accordance with development plan such product without limiting foregoing party shall commercially reasonable effort develop least licensed antibody product arising each project until first product arising such project been filed without limiting foregoing party shall also commercially reasonable effort cause first profit share product product containing antibody filed before party agree cooperate with each other carrying development plan each product neither party shall required undertake activity furtherance development plan other party meeting funding technology transfer other commitment forth this agreement that reasonably necessary have been performed order such first party perform relevant activity under development plan font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold development plan font font size style font size development activity with respect each project shall conducted party under development plan associated budget each development plan that will describe proposed overall program development each product therein including preclinical study toxicology formulation clinical trial regulatory plan other element necessary obtain regulatory approval such product each project development plan shall encompass nbsp with respect product which filing occurred rolling nbsp calendar year period nbsp with respect product which filing occurred rolling three nbsp calendar year period each development plan shall include summary estimated development cost expected during development process during applicable time period detailed description budget development activity proposed each calendar year each product font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold initial updated development plan font font size style font size shall reasonable effort agree upon initial high level development plan each project period beginning effective date ending december nbsp within hundred twenty effective date provided that until such development plan been adopted party will work good faith commencement activity each project accordance with preliminary action plan associated budget forth schedule development cost incurred thereunder shall considered development cost hereunder each development plan shall updated least annually incyte consultation with agenus each case submitted review approval later than october nbsp each calendar year during term each such updated development plan shall include with respect relevant project product therein extent possible nbsp outline overall development plan each product that forth major development task remaining accomplished prior submission filing regulatory approval extent such task known reasonably ascertained nbsp detailed description allocation responsibility proposed development activity time period font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size applicable each such product nbsp detailed financial forecast containing committed budget next calendar year solely product which been filed good faith estimate budget following nbsp calendar year member each project management team project project basis shall actively consult with another throughout term adjust specific work performed under applicable development plan conform evolving development technology result development work performed provided however that while minor adjustment such development plan that result budgeted funding exceeding then total amount budgeted calendar year such project made from time time upon approval applicable project management team significant change scope direction work change budgeted funding exceeding then total amount budgeted calendar year such project must approved absence which approval most recently approved development plan budget shall remain effect notwithstanding foregoing approve budget increase such increase nbsp associated with activity which party primary responsibility described section nbsp nbsp below party responsible such activity fund such activity itself such expenditure shall development cost allowable expense applicable hereunder nbsp subject clause associated with activity which agenus primary responsibility described section nbsp nbsp below nbsp incyte sole discretion fund such activity such expenditure shall considered allowable expense such expenditure relates profit share product profit share project will only included calculation profit loss under section nbsp after first commercial sale country such profit share product first profit share product under such profit share project credited against amount payable incyte agenus pursuant section nbsp with respect relevant royalty bearing product such expenditure relates such royalty bearing product relevant royalty bearing project provided however that such credit together with other offset against royalty provided under this agreement shall reduce royalty payable agenus calendar quarter applicable more than with such credit applied calendar quarter foregoing limit carried forward future calendar quarter font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold execution performance font font size style font size development plan each project shall allocate between party responsibility each activity described therein each party subcontract portion activity allocated under development plan permitted subcontractor provided that nbsp subcontracting party shall responsible performance permitted subcontractor nbsp subcontracting party shall reasonable effort have invention discovered made conceived each permitted subcontractor course performance such activity assigned subcontracting party manner consistent with section nbsp below licensed other party pursuant article nbsp above party shall shall cause their permitted subcontractor commercially reasonable effort conduct activity described each development plan doing shall prepare maintain proper record including laboratory notebook prepared maintained accordance with commercial scientific practice detailing such activity party acknowledge agree that each development plan shall presumptively font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size allocate primary responsibility nbsp antibody discovery antibody engineering preclinical development preparation agenus nbsp clinical trial medical affair activity commercialization incyte nbsp manufacturing including vendor selection oversight agenus unless until determines acting good faith that such allocation responsibility would have material adverse effect applicable project notwithstanding foregoing allocation responsibility nbsp project management team will coordinate supervise activity under each development plan including ensuring that each party optimizing allocation resource order achieve success area which allocated primary responsibility nbsp inds shall submitted incyte agenus behalf incyte unless allocates such responsibility agenus font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold development report font font size style font size nbsp each project management team shall provide with written report least once each calendar quarter summarizing reasonable detail party their respective affiliate activity progress related development licensed antibody product field territory including information concerning conduct clinical activity clinical trial application securing regulatory approval medical affair activity future planned development activity font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold abandoned development font font size style font size project project basis point time prior first commercial sale product arising such project nbsp development activity conducted good faith with intention advancing least product arising such project sole purpose preserving right hereunder have occurred party affiliate licensee sublicensee during least preceding nbsp significant constraint such development imposed regulatory authority force majeure event have been effect time during such period nbsp agenus complied with obligation under relevant development plan during such time period then incyte shall deemed have abandoned development such project abandoned development nbsp agenus reasonably concludes that incyte abandoned development then agenus shall deliver written notice incyte setting basis agenus conclusion nbsp incyte disagrees with agenus conclusion that incyte abandoned development then will meet within thirty discus disagreement nbsp agree after such discussion then term section nbsp nbsp shall apply resolve dispute nbsp incyte agrees dispute resolution mechanism section nbsp concludes that incyte abandoned development with respect project nbsp incyte previously been properly deemed have abandoned development with respect such project then within thereafter nbsp incyte either nbsp provided that incyte fails take such action within such period then agenus shall have right terminate this agreement with respect such project accordance with section nbsp nbsp provide agenus with written notice that chooses provide which case agenus shall have right terminate this agreement with respect such project accordance with section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold development option font font size style font size royalty bearing product royalty bearing product basis agenus shall have option fund development such royalty bearing product development option follows font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size within prior anticipated initiation first pivotal clinical trial royalty bearing product nbsp incyte shall notify agenus such anticipated initiation shall provide agenus with following information nbsp material clinical clinical data related analysis regulatory information submitted regulatory authority extent such data information provided behalf agenus update then current development plan associated budget including estimate overall cost each clinical trial annualized over course such clinical trial with respect such royalty bearing product collectively triggering information agenus shall have option fund further development such royalty bearing product exercisable providing incyte written notice within after receipt such information which case agenus shall fund thirty percent development cost such royalty bearing product incurred after date which such pivotal clinical trial initiated font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus timely exercise development option then within following each calendar quarter nbsp incyte shall prepare deliver agenus quarterly report detailing development cost incurred during such period with respect such developed product agenus shall prepare deliver incyte quarterly report detailing development cost incurred during such period with respect such developed product each party shall submit supporting information reasonably requested other party related such development cost included report within after receipt such request nbsp incyte shall issue invoice agenus that agenus shall have paid thirty percent aggregate development cost identified such quarterly report development quarterly payment provided that such invoiced amount together with other development cost invoiced agenus development activity conducted party their respective affiliate during such calendar year exceed total development cost budgeted development plan except extent such excess approved pursuant section nbsp nbsp hereof agenus shall amount payable under such invoice within forty five after receipt such invoice subject this section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus exercise development option with respect royalty bearing product reasonably undisputed development quarterly payment royalty rate section nbsp nbsp development royalty shall apply annual sale such developed product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus time upon prior written notice incyte prior written notice following consummation change control incyte elect cease funding portion development cost with respect developed product such event nbsp such product shall longer considered developed product nbsp incyte shall obligated development royalty sale such product only until such time agenus received incremental royalty equal total amount development cost paid agenus with respect development such product after exercise development option under section nbsp after which time royalty rate section nbsp nbsp shall apply font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold addition project program font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size ongoing basis during discovery period either party provide notice other party interest collaborating discovery project which notice shall include identity bullpen target proposed pursued discovery target reasonably detailed description scientific clinical rationale such project material clinical clinical data related antibody arising such proposed discovery project draft research development plan budget conduct such discovery project interaction between party regarding identification presentation review discussion discovery project selection discovery project inclusion program assumed project shall conducted coordinated through font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size within receipt such notice party receiving such proposal shall provide written notice proposing party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size interest including such discovery project program which time nbsp such discovery project shall immediately become assumed project purpose this agreement nbsp agenus shall stipulate whether such assumed project will profit share project royalty bearing project purpose this agreement nbsp shall prepare development plan budget such assumed project based appropriate research development plan budget included proposing party notice nbsp bullpen target which such discovery project directed shall cease bullpen target shall immediately become named target purpose this agreement font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size lack interest including such discovery project program which case proposing party shall irrevocably waive development manufacturing commercialization right such discovery project proposing party shall free develop manufacture commercialize antibody product arising such discovery project itself with affiliate third party without further obligation financial otherwise other party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size where agenus proposing party nbsp incyte indicate interest extending period time making decision regarding inclusion such discovery project program discovery option which case font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte shall reimburse agenus development cost incurred agenus affiliate conduct such discovery project accordance with research development plan budget previously presented updated agenus later than october nbsp each calendar year thereafter which updated plan budget shall consistent with level detail required development plan development budget hereunder within following receipt incyte invoice therefor font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size invoiced quarterly basis only extent that such invoiced amount together with other development cost reimbursed incyte development activity conducted agenus affiliate during such calendar year exceed total development cost budgeted research development plan relevant discovery project font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size discovery option exercised incyte upon written notice agenus delivered time during period beginning following incyte receipt notice that first product arising such discovery project been filed ending following incyte receipt notice that first phase clinical trial product arising such discovery project been completed receipt relevant data analysis period extending through earlier such date date which incyte exercise terminates discovery option option period font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size from time time during option period nbsp incyte reasonably request provided that request more frequent than semi annually shall considered unreasonable agenus shall promptly provide incyte material clinical clinical data related analysis regulatory information submitted regulatory authority with respect such product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte time upon written notice agenus nbsp exercise discovery option include such discovery project program whereupon provision section nbsp nbsp shall apply agenus shall have right exercise development option such product time forth section nbsp nbsp indicate lack interest including such discovery project program whereupon provision section nbsp nbsp nbsp shall apply font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size upon timely exercise discovery option incyte nbsp incyte shall agenus later than following delivery notice under which discovery option exercised license amount forth table below based stage development most advanced product arising such discovery project time discovery option exercised font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse margin left width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold stage nbsp nbsp development nbsp nbsp nbsp product nbsp arising nbsp nbsp nbsp discovery nbsp project font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold license nbsp font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font weight bold font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font weight bold font table style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse margin left width width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold font width valign style padding width style margin font size face time roman style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold font table style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte timely exercise discovery option agenus stipulates that such discovery project shall royalty bearing project nbsp incyte shall reimburse agenus fifty percent development cost incurred agenus affiliate conduct such discovery project with result that incyte would reimburse agenus hundred percent development cost incurred agenus with respect thereto only extent that such amount together with other development cost reimbursed incyte pursuant section nbsp exceed total development cost budgeted research development plan applicable discovery project within following delivery notice under which discovery option exercised addition nbsp incyte exercise discovery option prior completion first phase clinical trial product arising such discovery project agenus stipulates that such discovery project shall royalty bearing project then agenus shall entitled receive royalty forth section nbsp nbsp sale product arising such royalty bearing project nbsp incyte exercise discovery option after completion first phase clinical trial product arising such discovery project agenus stipulates that such discovery project shall royalty bearing project then such product shall considered option product hereunder agenus shall entitled receive royalty forth section nbsp nbsp sale such option product font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte exercise discovery option prior expiration discovery period otherwise notifies agenus lack interest including such discovery project program then during period following earlier expiration discovery period delivery such notice nbsp incyte subject section nbsp affiliate shall independently with third party develop manufacture commercialize field territory antibody that interacts with applicable discovery target product containing such antibody font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size notwithstanding anything contained this section nbsp contrary during each calendar year discovery period beginning with calendar year font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size commencing january nbsp party shall consider good faith selection least discovery project inclusion program assumed project absent compelling scientific business reason contrary font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold conversion profit share product font font size style font size agenus time prior written notice incyte prior written notice following consummation change control incyte elect cease funding share profit loss with respect profit share product convert program which such profit share product relates from profit share program royalty bearing program effective applicable notice period such event such profit share product shall become converted product applicable notice period royalty rate section nbsp nbsp shall apply annual sale such converted product only until such time agenus received incremental royalty equal total amount aggregate cumulative negative amount profit loss loss incurred agenus with respect converted product under section nbsp after which time royalty rate forth section nbsp nbsp shall apply font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold regulatory matter font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold responsibility font font size style font size nbsp incyte will control regulatory interaction with respect each product accordance with applicable development plan unless allocates such responsibility agenus which case reference incyte this section nbsp shall deemed refer agenus vice versa facilitate filing each product project management team applicable project shall agree upon appropriate plan transferring regulatory documentation from agenus incyte with agenus approval plan unreasonably withheld agenus shall commercially reasonable effort transfer regulatory documentation accordance with such plan incyte shall keep agenus reasonably informed connection with preparation regulatory documentation regulatory authority review regulatory documentation regulatory approval annual report annual assessment variation labeling each case with respect such product provided that incyte shall have right redact information extent related such product nbsp incyte shall respond within reasonable time frame reasonable inquiry agenus with respect information provided pursuant this section nbsp nbsp information disclosed pursuant this section nbsp nbsp shall confidential information incyte unless such information already confidential information agenus nbsp each party shall commercially reasonable effort conduct activity described this section nbsp which such party responsible font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold regulatory meeting correspondence font font size style font size agenus shall have right have senior experienced employee reasonably acceptable incyte bound obligation confidentiality forth article nbsp attend observer material scheduled face face meeting video conference teleconference involving participation personnel beyond regulatory expert with mhlw shall provided with advance access incyte material documentation prepared such meeting nbsp prior submission material correspondence applicable regulatory authority nbsp incyte shall sufficiently advance agenus review comment provide font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size agenus material correspondence with mhlw related such meeting nbsp incyte shall also provide agenus with copy material correspondence with mhlw relating development process obtaining regulatory approval product respond within reasonable time frame reasonable inquiry agenus with respect thereto font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold global safety database font font size style font size nbsp following initiation first phase clinical trial each product nbsp incyte shall establish hold maintain global safety database such product each global safety database into which shall enter information serious adverse event suspected reaction concerning product occurring anywhere world reported either party such database shall comply material respect with reasonably applicable pharmacovigilance anywhere where product being developed commercialized font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold manufacture supply font font size style font size agenus shall have responsibility selecting monitoring manufacturing vendor otherwise being responsible manufacturing activity with respect each product field territory accordance with applicable development plan time that determines acting good faith that some manufacturing responsibility particular project should transferred from agenus incyte because failure transfer such responsibility would reasonably likely have material adverse effect such project project management team applicable project shall agree upon appropriate plan transferring applicable manufacturing activity related know incyte with agenus having right approve plan involving activity such approval unreasonably withheld conditioned delayed agenus shall commercially reasonable effort transfer such manufacturing activity related know accordance with such plan such transfer shall considered development cost allowable expense party responsible manufacturing shall keep other party reasonably informed through connection with performance manufacturing activity product field nbsp responsible party shall respond within reasonable time frame reasonable inquiry other party with respect information provided pursuant this section nbsp nbsp information disclosed pursuant this section nbsp nbsp shall confidential information responsible party unless such information already confidential information other party nbsp each party shall commercially reasonable effort conduct activity described this section nbsp which such party responsible font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold medical affair activity font font size style font size incyte shall oversee monitor coordinate medical affair activity with respect product field territory which with respect developed product shall accordance with applicable development plan with respect profit share product shall accordance with applicable development plan commercialization plan applicable nbsp incyte shall keep agenus reasonably informed connection with performance medical affair activity developed product profit share product field nbsp incyte shall respond within reasonable time frame reasonable inquiry agenus with respect information provided pursuant this section nbsp nbsp unless already confidential information agenus font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size information disclosed pursuant this section nbsp nbsp shall confidential information incyte nbsp incyte shall commercially reasonable effort conduct activity described this section nbsp font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp commercialization font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold conduct commercialization activity font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold generally font font size style font size during term subject section nbsp nbsp incyte shall have sole right shall commercially reasonable effort commercialize product territory field such right includes right make business decision regarding design sale pricing promotion product field territory approve material used promotion product field territory including product packaging material used detailing product messaging content used promotion such product incyte shall commercially reasonable effort seek commercialization product shall commercially reasonable effort commercialize product field territory promptly after receipt regulatory approval therefor font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold commercialization plan font font size style font size incyte shall conduct commercialization activity with respect profit share product under rolling three nbsp year commercialization plan associated budget each commercialization plan that will describe proposed overall program commercialization such product field initial commercialization plan each profit share product shall prepared later than earlier initiation second phase clinical trial such product initiation first phase clinical trial such product each commercialization plan shall updated annually incyte consultation with agenus submitted review approval later than october nbsp each calendar year during term each such updated commercialization plan shall include nbsp overall commercialization plan applicable profit share product that forth major commercialization task remaining accomplished prior first commercial sale nbsp detailed description commercialization activity proposed following three nbsp calendar year nbsp detailed rolling three nbsp year financial forecast containing good faith estimated revenue forecast committed budget first calendar year good faith estimate budget following nbsp calendar year while minor adjustment commercialization plan made from time time incyte discretion change budgeted funding exceeding then total amount budgeted calendar year such profit share product must approved absence which approval most recently approved commercialization plan budget shall remain effect notwithstanding foregoing approve budget increase nbsp such increase activity conducted agenus promotion product nbsp incyte sole discretion fund such activity such expenditure shall allowable expense hereunder nbsp subject clause nbsp incyte fund such amount itself such expenditure shall allowable expense hereunder font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold execution performance font font size style font size incyte subcontract portion commercialization activity permitted subcontractor provided that nbsp incyte shall subcontract third party detailing activity profit share product which agenus exercised promotion option without first offering agenus right perform such activity nbsp incyte shall responsible performance permitted subcontractor nbsp incyte shall reasonable effort have invention discovered made conceived each permitted subcontractor course performance such activity assigned incyte manner consistent with section nbsp below licensed agenus applicable pursuant article nbsp above incyte shall shall cause permitted subcontractor commercially reasonable effort conduct activity described each commercialization plan font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold trademark font font size style font size incyte shall select trademark under which will market product provided that such trademark shall contain word antibody agenus shall such trademark incyte shall connection with packaging literature label other printed matter extent permitted expression effect that product were font font size style font size font font size style font size developed under license from agenus together with agenus logo font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold commercialization report font font size style font size nbsp incyte shall meeting provide reasonably detailed report incyte activity progress related commercialization product field territory including information concerning future planned commercialization activity font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold abandoned commercialization font font size style font size project project basis point time after first commercial sale product arising such project nbsp incyte itself through affiliate licensee sublicensees agenus permitted subcontractor third party distributor conducted commercialization activity least arising such project least period least preceding during that period nbsp incyte reasonably determined that commercialization least likely reduce overall commercial viability such product field territory nbsp significant constraint such commercialization imposed regulatory authority have been effect significant constraint such product imposed regulatory authority jurisdiction territory have been effect with respect such product which constraint nbsp incyte reasonably belief likely reduce overall commercial viability such product field territory which include regulatory hold recall nbsp force majeure event been effect which affect commercialization such product nbsp incyte itself through affiliate licensee sublicensees actively seeking regulatory approval pricing reimbursement approval nbsp such product promotion product agenus complied with promotion obligation during such time period then incyte shall deemed have abandoned commercialization such product abandoned commercialization nbsp agenus reasonably concludes that incyte abandoned commercialization then agenus shall deliver written notice incyte setting basis agenus conclusion nbsp incyte disagrees with agenus conclusion that incyte abandoned font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size commercialization then will meet within thirty discus disagreement nbsp agree after such discussion then term section nbsp shall apply resolve dispute nbsp incyte agrees dispute resolution mechanism section nbsp concludes that incyte abandoned commercialization with respect product nbsp incyte previously been properly deemed have abandoned commercialization with respect such project then within thereafter nbsp incyte either nbsp provided that incyte fails take such action within such period then agenus shall have right terminate this agreement with respect such project accordance with section nbsp nbsp provide agenus with written notice that chooses provide which case agenus shall have right terminate this agreement with respect such project accordance with section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold promotion option font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold promotion option font font size style font size profit share product profit share product basis agenus shall have option promote such profit share product united state term condition forth this section nbsp each promotion option incyte shall notify agenus least prior anticipated filing date first such profit share product united state shall provide agenus with following information nbsp incyte then current promotional plan with respect such profit share product which plan shall include nbsp description short long term vision such profit share product product positioning nbsp strength weakness opportunity threat swot analysis nbsp summary minimum level sale effort dedicated promotion profit share product including anticipated number detail target such detail nbsp good faith estimated budget detailing activity such profit share product each first period after first commercial sale such profit share product nbsp agenus exercise promotion option providing incyte written notice time after receipt incyte notice later than prior anticipated first commercial sale such profit share product united state font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold effect exercise promotion option font font size style font size nbsp agenus exercise promotion option with respect profit share product party shall good faith negotiate term written agreement setting forth agenus right responsibility with respect detailing such profit share product united state such agreement relevant promotion agreement which agreement would include following provision font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size party shall later than prior anticipated first commercial sale such profit share product united state number sale representative detailing such profit share product united state absent decision contrary event shall agenus responsible number sale representative detailing such profit share product which exceeds total ftes such profit share product united state font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size includable sale force cost indirect selling expense incurred agenus conducting promotion activity accordance with promotion agreement shall allowable expense hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size party shall establish joint commercialization committee oversee detailing relevant profit share product united state nbsp agenus shall entitled have nbsp representative group carrying function after effective date prior establishment nbsp shall have responsibility general oversight promotion detailing activity with respect such profit share product united state nbsp group carrying function after exercise promotion option prior establishment will meet quarterly more frequently agreed party nbsp term will determined party nbsp incyte shall have right make final decision with respect matter within purview related commercialization relevant profit share product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus sale representative will included training program with respect applicable profit share product that incyte provides sale representative detailing such profit share product cost reasonable pocket cost each party associated with such training shall considered allowable expense font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus sale representative shall provided with same promotional material including literature sample incyte provides similarly situated representative with cost such material considered allowable expense font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus shall comply with applicable with incyte commercialization compliance program other compliance related practice procedure font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size circumstance under which such promotion agreement terminated font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold additional activity font font size style font size incyte shall consider good faith request agenus involvement marketing other commercialization activity profit share product united state including participation single employee agenus brand team similar body established incyte with responsibility overall commercialization product cost incurred agenus connection with participation employee brand team similar body shall considered allowable expense hereunder font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp intellectual property font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold invention font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold ownership font font size style font size except expressly forth herein between party each party shall solely invention other know that made conceived otherwise discovered solely employee independent contractor agent such party affiliate patent right therein incyte shall invention other know that nbsp made conceived otherwise discovered solely employee independent contractor agent incyte affiliate under performance this agreement that constitute retrocyte display improvement incyte program invention nbsp subject next sentence made conceived otherwise discovered employee independent contractor agent either party their respective affiliate under performance this agreement that relate solely compound antibody active ingredient product that owned controlled incyte affiliate clarity other than licensed antibody product invention know clause patent right therein incyte other invention agenus behalf itself affiliate agrees assign hereby assign incyte right title interest incyte other invention knowingly made conceived otherwise discovered employee independent contractor agent agenus affiliate under performance this agreement agenus font font size style font size shall invention font font size style font size other know font font size style font size that nbsp made conceived otherwise discovered solely employee independent contractor agent font font size style font size agenus font font size style font size affiliate under performance this agreement that constitute retrocyte display improvement incyte other invention nbsp subject next sentence made conceived otherwise discovered employee independent contractor agent either party their respective affiliate under performance this agreement that constitute retrocyte display improvement font font size style font size incyte behalf itself affiliate agrees assign hereby assign agenus right title interest retrocyte display improvement knowingly made conceived otherwise font font size style font size discovered employee independent contractor agent incyte affiliate under performance this agreement party shall jointly invention font font size style font size other know font font size style font size that made conceived authored otherwise discovered employee independent contractor agent both agenus affiliate incyte affiliate that nbsp constitute retrocyte display improvement incyte other invention nbsp would deemed jointly conceived invented authored otherwise jointly owned party under united state applicable foreign jurisdiction joint invention each party shall equal undivided interest each joint invention patent right therein joint patent right agenus interest joint patent right included agenus patent right licensed exclusively incyte pursuant subject limitation forth section nbsp event that jurisdiction requires consent owner owner grant license right under otherwise exploit joint invention each party hereby grant subject term exclusive license granted hereunder other party sublicenseable right license exploit such joint invention without requirement accounting other than forth this agreement font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold inventorship font font size style font size determination inventorship shall made accordance with patent party shall attempt good faith resolve dispute regarding ownership invention patent right other intellectual property right therein event party unable resolve such dispute within thirty after receipt notice dispute such dispute will resolved independent patent counsel engaged regularly employed past nbsp year either party reasonably acceptable both party decision such independent patent counsel will binding party expense such patent counsel will shared equally party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold assignment font font size style font size each party shall require affiliate affiliate employee shall reasonable effort have each permitted subcontractor agent assign their right title interest invention such party affiliate such party shall shall require affiliate assign with respect joint invention joint patent right relevant portion their right title interest invention other party necessary vest with respect joint invention joint patent right joint right title interest such invention forth section each party shall shall cause affiliate affiliate employee shall reasonable effort have each permitted subcontractor agent cooperate take additional action execute such agreement instrument document reasonably required perfect such party right title interest invention patent right therein font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold cooperation font font size style font size each party hereby agrees nbsp reasonable effort make employee agent consultant reasonably available other party other party authorized attorney agent representative extent reasonably necessary enable such party undertake prosecution patent right contemplated this agreement nbsp cooperate necessary appropriate with other party gaining patent term extension wherever applicable patent right that subject this agreement accordance with section nbsp nbsp endeavor good faith coordinate effort with other party minimize avoid interference with prosecution other party patent right that subject this agreement avoidance doubt each party agrees that shall reasonable effort cause employee agent consultant provide information required other party comply with relevant duty disclosure required applicable united state other jurisdiction font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold joint research agreement font font size style font size party acknowledge agree that this agreement joint research agreement defined america invents nbsp notwithstanding anything contrary this article nbsp party will reasonable effort cooperate coordinate their activity with respect submission filing other activity support thereof font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold prosecution patent right font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size subject section nbsp nbsp agenus shall have sole right prosecute agenus platform patent right first right prosecute agenus patent font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size right nbsp incyte shall have first right prosecute incyte program patent right joint patent right sole right prosecute incyte including patent right resulting from incyte other invention that incyte program patent right joint patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size with respect agenus patent right nbsp incyte program patent right joint patent right party responsible prosecution shall consult with keep other party fully informed important issue relating prosecution such patent right shall furnish other party copy document relevant such prosecution sufficient time prior filing such document allow review comment other party extent possible reasonable exercise discretion party responsible prosecution shall incorporate such comment font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus elect prosecute agenus patent right whether worldwide with respect particular country including electing file patent application with respect thereto allow such agenus patent right lapse become abandoned unenforceable then agenus shall promptly notify incyte writing which such notice shall least sixty prior lapse abandonment such agenus patent right thereafter nbsp incyte required sole expense sole discretion prosecute such agenus patent right through counsel choosing event that incyte undertakes such prosecution agenus shall provide incyte reasonable assistance cooperation relation thereto including specified section nbsp nbsp above including providing necessary power attorney executing other required document instrument font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte elect prosecute incyte program patent right joint patent right whether worldwide with respect particular country including electing file patent application with respect thereto allow such incyte program patent right joint patent right lapse become abandoned unenforceable then incyte shall promptly notify agenus writing which such notice shall least sixty prior lapse abandonment such joint patent right thereafter agenus required sole expense sole discretion prosecute such incyte program patent right joint patent right through counsel choosing event that agenus undertakes such prosecution nbsp incyte shall provide agenus reasonable assistance cooperation relation thereto including specified section nbsp nbsp above including providing necessary power attorney executing other required document instrument font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold third party infringement font font size style font size font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold notice font font size style font size each party shall promptly report writing other party during term nbsp known suspected infringement agenus patent right nbsp incyte program patent right joint patent right licensed infringement covering licensed antibody product field anywhere territory including certification regarding agenus patent right nbsp incyte program patent right joint patent right covering such product that such party receives pursuant font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size nbsp such similar exist jurisdiction other than united state paragraph notice pursuant nbsp such similar exist jurisdiction other than united state biosimilar notice which paragraph notice biosimilar notice shall provided other party within five nbsp business after receipt thereof nbsp known suspected unauthorized misappropriation agenus know incyte know field which such party becomes aware each party shall provide other party with available evidence supporting such infringement suspected infringement unauthorized misappropriation suspected unauthorized misappropriation font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold infringement action font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus patent right font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus shall have initial right obligation initiate suit take other appropriate action that belief reasonably required protect agenus know agenus patent right excluding joint know joint patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size extent that licensed infringement pertains agenus patent right covering product territory font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus shall give incyte advance notice intent file file such suit take take such action reason therefor font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus file such suit take such action within shorter nbsp after agenus becomes aware such licensed infringement after agenus receives relevant paragraph notice with respect biosimilar notice such longer period time accordance with nbsp such shorter period time avoid loss material enforcement right remedy then subject section nbsp nbsp incyte shall have right obligation initiate suit take other appropriate action protect agenus patent right against such licensed infringement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size relevant product which such licensed infringement pertains profit share product cost expense incurred either party with respect enforcement action pursuant this subsection nbsp shall patent trademark cost otherwise cost expense incurred either party with respect enforcement action pursuant this subsection nbsp shall borne party conducting enforcement action font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte program patent right joint patent right font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte shall have initial right obligation initiate suit take other appropriate action that belief reasonably required protect incyte program know incyte program patent right including joint know joint patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size extent that licensed infringement pertains incyte program patent right joint patent right covering product territory font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte shall give agenus advance notice intent file file such suit take take such action reason therefor font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte file such suit take such action within shorter nbsp after incyte becomes aware such licensed infringement after incyte receives relevant paragraph notice with respect biosimilar notice such longer period time accordance with nbsp such shorter period time avoid loss material enforcement right remedy then subject section nbsp agenus shall have right obligation initiate suit take other appropriate action protect such incyte program patent right joint patent right against such licensed infringement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size relevant product which such licensed infringement pertains profit share product cost expense incurred either party with respect enforcement action pursuant this subsection nbsp shall patent trademark cost otherwise cost expense incurred either party with respect enforcement action pursuant this subsection nbsp shall borne party conducting enforcement action font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold conduct action font font size style font size party initiating suit shall have sole exclusive right select counsel suit initiated under section nbsp required under applicable order such party initiate maintain such suit other party shall join party suit requested party initiating suit other party shall provide reasonable assistance party initiating suit connection therewith other party shall have right participate represented suit described section nbsp nbsp counsel expense party initiating suit provided section nbsp nbsp shall nbsp keep other party promptly informed nbsp from time time consult with other party regarding status such suit action nbsp provide other party with copy material document complaint answer counterclaim material motion order court memoranda legal brief interrogatory response deposition material trial font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin font size face time roman style font size filing expert report affidavit filed court transcript hearing trial testimony trial exhibit notice appeal filed otherwise relating such suit action nbsp without such other party consent settle such suit manner which would nbsp have adverse effect such other party patent right such other party program right hereunder nbsp admission liability behalf such other party provided however that party initiating such suit settle such suit without such consent such settlement involves only receipt money from payment money such third party party initiating such suit make such payment such third party font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold recovery font font size style font size extent that such suit action pertains product recovery obtained result proceeding described section nbsp nbsp from counterclaim similar claim asserted proceeding described section nbsp settlement otherwise shall applied following order priority font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size first party shall reimbursed pocket cost incurred them connection with such proceeding which reimbursement nbsp relevant product which relevant licensed infringement pertains profit share product developed product shall made proportion their respective obligation fund patent trademark cost such product nbsp otherwise shall made reimburse each party full such recovery sufficient rata proportion such pocket cost borne each font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size second remainder shall paid incyte shall considered sale such product relevant country subject nbsp relevant product which relevant licensed infringement pertains profit share product calculation profit loss pursuant section nbsp with respect such profit share product nbsp relevant product which relevant licensed infringement pertains royalty bearing product payment relevant royalty agenus pursuant section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold claimed infringement font font size style font size event that third party time provides written notice claim brings action suit proceeding against party affiliate permitted sublicensee claiming infringement such third party patent right unauthorized misappropriation such third party know based upon assertion claim arising research development manufacture commercialization other product field such party third party infringement claim such party shall promptly notify other party claim commencement such action suit proceeding enclosing copy claim paper served subject section nbsp party affiliate permitted sublicensee against which such third party infringement claim brought shall have sole right obligation defend such third party infringement claim event party shall reasonably assist another cooperate such litigation cost pocket cost incurred party connection with defense third party infringement claim loss payable either party result thereof nbsp shall patent trademark cost hereunder relevant product which such third party infringement claim pertains profit share product nbsp font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size otherwise shall borne party that primarily responsible activity that subject third party infringement claim font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold patent invalidity claim font font size style font size third party time asserts claim that agenus patent right nbsp incyte program patent right joint patent right covering product invalid otherwise unenforceable invalidity claim whether defense infringement action brought agenus incyte pursuant section nbsp declaratory judgment action third party infringement claim brought against agenus incyte party controlling such patent right incyte with respect joint patent right shall have first right obligation defend such invalidity claim other party shall cooperate with party controlling such patent right preparing formulating response such invalidity claim agenus defend invalidity claim brought against agenus patent right incyte defend invalidity claim brought against incyte program patent right joint patent right other party defend such invalidity claim coordination provision section nbsp nbsp shall apply such invalidity claim mutatis mutandis they apply licensed infringement suit neither party shall without consent other party settle compromise invalidity claim manner which would nbsp have adverse effect such other party patent right such other party program right hereunder nbsp admission liability behalf such other party provided however that party initiating such suit settle such suit without such consent such settlement involves only receipt money from payment money such third party party initiating such suit make such payment such third party extent such invalidity claim raised defense infringement action brought agenus incyte pursuant section nbsp expense provision section nbsp shall apply counsel party controlling infringement action shall ministerial liaison with court extent such invalidity claim raised third party infringement claim brought against party expense provision section nbsp shall apply with respect thereto party against whom invalidity claim brought shall ministerial liaison with court font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold patent term extension font font size style font size incyte shall have sole authority obtain patent term extension patent right covering product provided however that incyte shall reasonably consider input from agenus with respect extension agenus patent right agenus shall applicable file documentation take other action obtain such patent term extension font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold patent marking font font size style font size incyte shall comply with applicable patent marking statute country which product covered agenus patent right joint patent right sold font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp financial provision font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold license font font size style font size nbsp consideration right license sublicenses granted incyte agenus under section nbsp with respect four nbsp project included program effective date nbsp incyte shall make agenus nonrefundable creditable payment font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size million dollar within nbsp after effective date foregoing license shall deemed allocated among each four nbsp project included program manner forth schedule font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold project access font font size style font size consideration access discovery project during discovery period nbsp incyte shall make agenus refundable creditable payment fifteen million dollar within nbsp after effective date font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold sharing profit loss font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size subject section nbsp profit loss shall allocated fifty percent each incyte agenus such that incyte agenus shall each share fifty percent profit loss with respect each profit share product until development commercialization such profit share product permanently discontinued font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size from after effective date party shall conduct quarterly reconciliation profit loss follows profit share product profit share product basis font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size within after each calendar quarter each party shall submit other party preliminary written report setting forth following information estimated where necessary font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size actual revenue expense included profit loss such product first nbsp month such calendar quarter including applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size sale unit sale value such profit share product territory made incyte incyte related party during such nbsp month period together with accounting itemized deduction from gross invoice price sale font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size profit share product proceeds such profit share product received from third party territory during such nbsp month period font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size relevant allowable expense incurred each party affiliate with respect such profit share product during such nbsp month period font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size good faith estimate revenue expense included profit loss such product last month such calendar quarter financial reporting purpose font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size within after each calendar quarter each party shall submit other party final written report setting forth applicable font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size sale unit sale value such profit share product territory made incyte incyte related party during such calendar quarter together with accounting itemized deduction from gross invoice price sale font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size profit share product proceeds such profit share product received from third party territory during such calendar quarter font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size relevant allowable expense incurred such party affiliate with respect such profit share product during such calendar quarter font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size within after receipt report pursuant subparagraph nbsp above nbsp incyte shall submit agenus written reconciliation report setting forth reasonable detail calculation profit loss amount required withheld calculation amount owed incyte agenus agenus incyte case order ensure sharing profit loss forth this section nbsp proper allocation withholding pursuant section nbsp amount payable with respect profit loss after appropriate adjustment withholding shall paid incyte agenus appropriate affiliate case within following receipt invoice such amount font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size addition providing information forth subsection nbsp above each party affiliate case shall provide reasonable supporting documentation allowable expense included calculation profit loss manner determined font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold reimbursement development cost font font size style font size subject section nbsp incyte shall reimburse agenus development cost incurred agenus affiliate nbsp with respect each royalty bearing product accordance with relevant development plan nbsp constituting patent trademark cost pertaining bullpen target provided section nbsp each case within following receipt incyte invoice therefor only extent that such invoiced amount together with other development cost reimbursed incyte development activity conducted agenus affiliate during such calendar year exceed total development cost budgeted development plan relevant royalty bearing product except extent such excess approved pursuant section nbsp nbsp hereof font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold milestone payment font font size style font size incyte shall make following refundable creditable milestone payment agenus upon achievement each following milestone incyte incyte related party font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold profit share product font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size milestone payment event profit share product font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold milestone nbsp event font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold payment font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font weight bold font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font weight bold font width valign style padding width style margin font size face time roman style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold font table style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size profit share product profit share product basis font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size clarity none milestone payment forth this section nbsp nbsp shall allowable expense hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold royalty bearing product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size milestone payment event royalty bearing product font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold milestone nbsp event font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold payment font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font weight bold font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font weight bold font width valign style padding width style margin font size face time roman style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold font width valign style padding width style margin font size face time roman style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold font width valign style padding width style margin font size face time roman style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold font width valign style padding width style margin font size face time roman style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold font table style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold font font size style font size font style margin text indent font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse margin left width width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold font table align right style margin text align right font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size more than milestone payment forth earned concurrently based example limitation then incyte shall agenus milestone payment forth both section total font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size with respect royalty bearing product which been profit share product prior agenus exercise right pursuant section nbsp only those milestone event which triggered such royalty bearing product after period period event change control applicable described section nbsp shall payable pursuant this section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold milestone payment font font size style font size incyte shall notify agenus achievement each foregoing milestone within after each such achievement milestone payment shall reflected invoice provided incyte agenus such invoice shall payable incyte within after date invoice received font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold royalty font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold royalty rate font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold royalty bearing product font font size style font size except with respect developed product combination product option product converted product nbsp incyte shall agenus royalty sale each royalty bearing product royalty bearing product royalty bearing product basis each calendar year follows font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold annual nbsp nbsp sale nbsp nbsp nbsp relevant nbsp royalty bearing nbsp product font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold royalty nbsp rate font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size portion than equal font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font width valign style padding width style margin font size face time roman style font size portion greater than than equal font width valign bottom style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size portion greater than than equal font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold font width valign style padding width style margin font size face time roman style font size portion greater than font width valign bottom style padding width style margin font size face time roman style font size nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font table style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold combination product font font size style font size with respect combination product other than developed product nbsp incyte shall agenus royalty sale each combination product combination product combination product basis each calendar year follows font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold annual nbsp nbsp sale nbsp nbsp nbsp relevant nbsp combination nbsp product font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold royalty nbsp rate font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size portion than equal font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font weight bold font width valign style padding width style margin font size face time roman style font size portion greater than than equal font width valign bottom style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size portion greater than than equal font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold font width valign style padding width style margin font size face time roman style font size portion greater than font width valign bottom style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold font table style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold developed product font font size style font size with respect developed product nbsp incyte shall agenus royalty sale each such developed product developed product developed product basis each calendar year follows font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold annual nbsp nbsp sale nbsp nbsp nbsp relevant nbsp developed nbsp product font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold royalty nbsp rate font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size portion than equal font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font weight bold font width valign style padding width style margin font size face time roman style font size portion greater than than equal font width valign bottom style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size portion greater than font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold font table style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold option product font font size style font size incyte shall agenus royalty sale each option product option product option product basis each calendar year follows font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold annual nbsp nbsp sale nbsp nbsp nbsp relevant nbsp option nbsp product font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold royalty nbsp rate font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size portion than equal font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font weight bold font width valign style padding width style margin font size face time roman style font size portion greater than than equal font width valign bottom style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size portion greater than than equal font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold font width valign style padding width style margin font size face time roman style font size portion greater than font width valign bottom style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold font table style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold converted product font font size style font size with respect converted product nbsp incyte shall agenus royalty sale each such converted product converted product converted product basis rate forth section nbsp nbsp until such time provided section nbsp thereafter rate forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold royalty term font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size royalty payable under this section nbsp shall paid incyte royalty bearing product royalty bearing product country country basis from date first commercial sale such royalty bearing product relevant country period which longest nbsp date which agenus patent right nbsp incyte program patent right joint patent right containing valid claim covering manufacture commercialization other such royalty bearing product country sale have expired nbsp expiration regulatory exclusivity such royalty bearing product such country nbsp following date first commercial sale such royalty bearing product such country each such term with respect royalty bearing product country royalty term font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size notwithstanding anything contrary herein event that with respect royalty bearing product country nbsp royalty term such royalty bearing product such country continues solely section nbsp nbsp generic competition exists with respect such royalty bearing product field such country calendar quarter then royalty rate such country such royalty bearing product will thereafter reduced applicable rate section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold stacking font font size style font size agenus shall responsible payment amount third party under licr agreement other agreement with third party effect effective date which agenus affiliate party which them bound incyte nbsp determines good faith that order avoid infringement patent right licensed hereunder reasonably necessary obtain license after effective date from third party under patent right controlled third party covering composition method licensed antibody order commercialize product field country territory royalty under such license including connection with settlement patent infringement claim nbsp shall subject final court other binding order ruling requiring payment including payment royalty third party patent holder respect development manufacture commercialization product field country territory then nbsp case profit share product royalty other consideration payable such third party shall patent trademark cost after first commercial sale country territory applicable product nbsp case royalty bearing product amount incyte royalty payment under section nbsp nbsp subject section nbsp with respect sale such royalty bearing product such country calendar quarter shall reduced royalty actually paid incyte such third party that reasonably appropriately font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size allocable such royalty bearing product field territory during such calendar quarter provided however that event shall aggregate deduction under this section nbsp nbsp reduce royalty payment made agenus respect sale such royalty bearing product pursuant section nbsp nbsp subject section nbsp calendar quarter amount that represents than greater nbsp royalty otherwise payable such calendar quarter nbsp sale applicable royalty bearing product during such calendar quarter with such deduction applied calendar quarter foregoing limit carried forward future calendar quarter font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold license font font size style font size upon expiration royalty term with respect royalty bearing product country license granted agenus incyte pursuant section nbsp shall deemed exclusive fully paid irrevocable perpetual with respect such royalty bearing product such country font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold multiple royalty font font size style font size only royalty shall with respect each sale royalty bearing product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold royalty report payment font font size style font size nbsp incyte shall deliver agenus within after each calendar quarter royalty report such calendar quarter together with required payment pursuant section nbsp nbsp such report shall indicate country country basis gross sale deduction taken from gross sale reach sale sale calculation royalty from sale with respect thereto each determined accordance with this agreement with respect sale royalty bearing product nbsp payment agenus pursuant this agreement shall made dollar wire transfer immediately available fund account designated advance agenus font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold audit font font size style font size nbsp period next following each calendar year each party shall keep shall cause affiliate keep full true accurate book record containing particular relevant calculation development cost profit loss sale including with respect sale relevant statement obtained from permitted sublicensees sufficient detail enable other party verify amount payable under this agreement each party shall have right more than once during calendar year expense have book record other party affiliate applicable audited independent certified public accounting firm that nbsp largest revenue accounting firm united state mutually acceptable both party audit under this section nbsp shall conducted principal place business financial personnel with responsibility preparing maintaining such record during normal business hour upon least prior written notice sole purpose verifying amount payable such party under this agreement information data reviewed audit conducted under this section nbsp shall used only purpose verifying amount payable party under this agreement shall treated confidential information audited party subject term this agreement auditing party shall cause accounting firm enter into reasonably acceptable confidentiality agreement with audited party affiliate applicable accounting firm shall disclose auditing party only whether calculation development cost profit loss font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size royalty correct incorrect specific detail concerning discrepancy audit demonstrates that payment owed under this agreement have been understated audited party shall balance auditing party which shall paid together with interest accordance with section nbsp nbsp further amount understatement greater than amount owed auditing party with respect audited period then audited party shall reimburse auditing party reasonable pocket cost audit nbsp audit demonstrates that payment owed under this agreement have been overstated audited party shall entitled credit such amount against payment auditing party payment owed party under this section nbsp shall made within after result audit delivered party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold matter font font size style font size nbsp royalty milestone profit share payment other amount payable party payor other party payee pursuant this agreement each payment shall made without deduction withholding except extent that such deduction withholding required effect time payment event that payor required applicable deduct withhold over collectively withhold withholding from respect such payment payor shall nbsp notify payee such requirement promptly upon first becoming aware thereof nbsp withhold full amount such withholding relevant taxing authority when nbsp after withholding amount such payment payee together with documentation confirming amount fact associated withholding amount withholding required withheld respect payment shall nbsp determined good faith discretion payor with regard valid documentation previously provided payor benefit payee form substance reasonably satisfactory payor that support reduced rate withholding respect payment nbsp treated purpose this agreement having been duly timely paid payor benefit payee party agree cooperate good faith permit payee recover excess withhold previously withheld date execution this agreement each party will deliver other accurate complete internal revenue service form nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold currency exchange font font size style font size nbsp payment made party other party shall made dollar nbsp case sale product outside united state royalty profit share payment shall converted dollar using average daily foreign exchange rate published wall street journal eastern edition calendar quarter which such payment occurred font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold late payment font font size style font size nbsp without limiting other right remedy available party hereunder paying party amount before date paying party shall such party interest such amount from after date such payment under this agreement rate annum equal then current prime rate effect published wall street journal eastern edition plus maximum applicable legal rate calculated total number payment delinquent provided that with respect disputed payment interest payment shall until such dispute resolved interest which shall payable thereon shall based finally font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size resolved amount such payment calculated from original date which disputed payment through date which payment actually made font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold general payment provision font font size style font size nbsp notwithstanding anything contrary this agreement nbsp there shall double counting expense revenue within between among definition profit loss development cost component thereof nbsp profit loss development cost component thereof shall determined from book record applicable party affiliate maintained accordance with accounting standard font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp viii term termination font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold agreement term font font size style font size nbsp term this agreement shall commence effective date shall continue long nbsp product being developed commercialized nbsp discovery period option period remains effect unless terminated early accordance with section nbsp term provided however that article nbsp xiii shall effective execution date nbsp notwithstanding above there ongoing dispute term forth above this agreement shall remain full force effect until such dispute resolved font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold termination font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold termination convenience font font size style font size nbsp time after first font font size style font size position relative font font size style font size anniversary effective date nbsp incyte elect terminate this agreement entirety more project providing twelve month prior written notice agenus provided that time after such notice incyte agenus accelerate effective date such termination providing thirty prior written notice incyte such accelerated effective date font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold termination material breach font font size style font size nbsp either party breaching party belief that other party breaching party material breach this agreement then breaching party deliver notice such breach breaching party nbsp breaching party fails cure such breach initiate such step would considered reasonable effectively cure such breach thereafter diligently pursues such cure within after receipt such notice breach case payment amount hereunder breaching party terminate this agreement upon written notice breaching party nbsp notwithstanding foregoing party dispute termination then section nbsp nbsp shall apply font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold termination incyte challenge agenus font font size style font size except connection with infringement action brought agenus licensors affiliate sublicensees against incyte incyte related party incyte incyte related party directly indirectly nbsp initiate request interference opposition similar proceeding with respect agenus patent right nbsp make file maintains claim demand lawsuit cause action challenge validity enforceability agenus patent right nbsp opposes font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size extension grant supplementary protection certificate with respect agenus patent right agenus shall have right terminate this agreement upon prior written notice incyte incyte incyte related party applicable withdrawn such action before such notice period font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold termination abandoned development commercialization font font size style font size nbsp incyte abandoned development abandoned commercialization applicable agenus elect terminate this agreement relevant project provided section nbsp providing incyte written notice such termination such termination effective immediately upon written notice incyte notwithstanding foregoing incyte dispute termination then section nbsp nbsp shall apply font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold termination competing program following change control font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size event that incyte undergoes change control acquirer incyte person which immediately prior such change control affiliate such acquirer engaged research development manufacture commercialization field territory compound antibody that interacts with profit share target nbsp target developed product therapeutic preparation containing such compound antibody date such change control then agenus elect terminate this agreement applicable profit share product developed product only immediately upon written notice incyte font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size event that agenus undergoes change control acquirer agenus person which immediately prior such change control affiliate such acquirer engaged research development manufacture commercialization field territory compound antibody that interacts with profit share target nbsp target developed product therapeutic preparation containing such compound antibody date such change control then incyte elect terminate this agreement applicable profit share product developed product only immediately upon written notice agenus font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold termination dispute font font size style font size nbsp party give notice termination under section nbsp party dispute whether incyte abandoned development abandoned commercialization accordance with section nbsp applicable agenus give notice termination under section nbsp nbsp incyte give notice termination under section nbsp other party dispute whether such notice proper then issue whether relevant party breached this agreement nbsp incyte abandoned development abandoned commercialization notice properly given pursuant section nbsp nbsp nbsp shall resolved accordance with section nbsp agreement shall remain full force effect until such dispute resolved nbsp cure period shall tolled during such dispute resolution process result such dispute resolution process determined that notice termination proper then breaching party incyte applicable shall entitled remainder relevant cure period such font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size termination shall only effective relevant breach abandoned development abandoned commercialization cured otherwise addressed accordance with this agreement during such period nbsp other hand result dispute resolution process determined that notice termination improper then termination shall have occurred shall occur result such notice this agreement shall remain full force effect font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold effect termination font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size upon termination this agreement with respect particular project entirety incyte pursuant section nbsp nbsp agenus pursuant section nbsp following provision shall apply solely with respect each terminated project where terminated project mean each terminated project this agreement terminated entirety each project terminated product mean product licensed antibody arising from relevant terminated project provided however that reference terminated product shall exclude right granted agenus with respect compound antibody active ingredient that owned controlled incyte affiliate third party which clarity licensed antibody product other than combination product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size license granted agenus incyte under section nbsp shall terminate incyte shall have right exercise right under agenus font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte hereby grant agenus from after such termination exclusive worldwide royalty bearing section nbsp nbsp below license with right grant sublicenses nbsp under incyte date such termination solely extent that such license necessary develop manufacture commercialize terminated product field territory nbsp license granted agenus under incyte program patent right incyte program know pursuant section nbsp nbsp shall survive font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size provision article nbsp other than section nbsp shall terminated provided that between party right obligation party prosecute enforce incyte program patent right joint patent right that solely cover terminated product nbsp shall reversed necessary agenus then exercise first right prosecute enforce such incyte program patent right joint patent right nbsp incyte shall transition prosecution enforcement responsibility agenus with respect such incyte program patent right joint patent right including execution such document necessary effect such transition font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte shall promptly transfer assign agenus incyte affiliate right title interest trademark nbsp incyte house mark trademark containing word incyte owned incyte used font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size product field territory owned incyte used terminated product field territory font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte shall provide agenus fair accurate summary report status development commercialization terminated product field each country territory through effective date termination within after such termination font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size extent permitted applicable nbsp incyte shall transfer agenus solely development manufacture commercialization terminated product field territory nbsp incyte entire right title interest preclinical clinical data other supporting data including pharmacology toxicology chemistry biology data documented technical other information material extent related development manufacture commercialization terminated product field territory provided that incyte retain single copy such item record such additional copy required applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size extent permitted applicable nbsp incyte shall transfer agenus regulatory documentation regulatory approval including reimbursement pricing approval global safety database record regulatory interaction each case extent related terminated product field territory that incyte control effective date such termination incyte restricted under applicable from transferring ownership foregoing item agenus nbsp incyte shall grant hereby grant agenus designee right reference such item incyte shall take permitted action reasonably necessary effect such transfer grant right reference agenus font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size viii font font size style font size font font size style font size extent reasonably requested agenus nbsp incyte shall transfer agenus license agreement other contract between incyte third party that specific terminated product field territory including applicable clinical trial manufacturing agreement extent such agreement effect effective date termination such assignment transfer permitted cost expense incyte facilitate introduction agenus applicable permitted subcontractor licensors manufacturing vendor clinical trial site clinical trial investigator like font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus shall have right purchase from incyte inventory terminated product field territory held incyte effective date termination price equal incyte manufacturing cost determined accordance with accounting standard only following condition date supply nbsp such product meet applicable release specification nbsp continued such product cause objectively valid safety concern which agenus willing indemnify incyte unless pursuant this agreement manufacturing supply similar agreement between among font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size party their affiliate nbsp incyte affiliate obligated indemnify agenus affiliate with respect manufacture relevant unit such product agenus shall notify incyte within after effective date termination whether agenus elect exercise such right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size extent permitted applicable nbsp incyte shall transfer agenus promotional material customer data competitive intelligence data market research other material information data extent related commercialization terminated product field territory that controlled incyte effective date such termination extent necessary reasonably useful commercialization such product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size agenus shall incyte terminated product terminated product basis royalty sale each terminated product under authority agenus affiliate licensee sublicensees specified following chart accordance with same schedule other term condition incyte would have otherwise been obligated royalty agenus royalty bearing product under article nbsp mutatis mutandis font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse margin left width width valign bottom style border none border bottom solid windowtext padding width style margin font size face time roman style font size font weight bold stage nbsp nbsp development nbsp nbsp nbsp relevant nbsp terminated nbsp product nbsp nbsp nbsp effective nbsp date nbsp nbsp termination font width valign bottom style padding width align center style margin text align center font size face time roman style font size font weight bold nbsp font width valign bottom style border none border bottom solid windowtext padding width align center style margin text align center font size face time roman style font size font weight bold royalty nbsp rate font width valign bgcolor cceeff style background cceeff border none padding width style margin font size face time roman style font size font weight bold font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold nbsp font width valign bgcolor cceeff style background cceeff border none padding width align center style margin text align center font size face time roman style font size font weight bold font width valign style padding width style margin font size face time roman style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold font width valign style padding width style margin font size face time roman style font size font weight bold font width valign bottom style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width align center style margin text align center font size face time roman style font size font weight bold font width valign bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold font width valign bottom bgcolor cceeff style background cceeff padding width style margin font size face time roman style font size font weight bold nbsp font width valign bgcolor cceeff style background cceeff padding width align center style margin text align center font size face time roman style font size font weight bold font table style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size clarity section nbsp nbsp nbsp shall apply font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size event termination this agreement with respect particular project incyte under section nbsp nbsp agenus under section nbsp nbsp this agreement shall continue full force effect with respect project unaffected such partial termination provision this section nbsp shall apply solely with respect project product nbsp arising project nbsp that affected such partial termination font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size upon termination this agreement incyte accordance with section nbsp nbsp section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size license granted incyte agenus pursuant section nbsp shall incyte discretion terminate survive font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size license granted agenus incyte pursuant section nbsp shall remain effect font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size right obligation party pursuant section shall remain effect font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte obligation agenus royalty under section nbsp milestone under section nbsp shall survive provided however solely case termination this agreement incyte accordance with section nbsp nbsp incyte shall have right exercisable delivery written notice agenus against reduce amount royalty agenus under section nbsp amount unindemnified loss that actually incurred incyte arising directly material breach this agreement that resulted such termination with dispute over amount such loss resolved accordance with section nbsp hereof font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte discretion profit share product developed product shall become royalty bearing product term forth section nbsp without application notice period contained therein agenus shall have further obligation fund portion allowable expense incurred thereafter such profit share product development cost incurred thereafter such developed product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size extent reasonably requested incyte agenus shall transfer incyte license agreement other contract between agenus third party that specific product field territory including applicable manufacturing agreement excluding licr agreement extent such agreement effect effective date termination such assignment transfer permitted cost expense agenus facilitate introduction incyte applicable permitted subcontractor licensors manufacturing vendor like font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size incyte shall have right purchase from agenus inventory product field territory held agenus effective date termination price equal agenus manufacturing cost determined accordance with accounting standard only following condition date supply nbsp such product meet applicable release specification nbsp continued such product cause objectively valid safety concern which incyte willing indemnify agenus unless pursuant this agreement manufacturing supply similar agreement between among party their affiliate agenus affiliate obligated indemnify incyte affiliate with respect manufacture relevant unit such product incyte shall notify agenus within nbsp month after effective date termination whether incyte elect exercise such right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size viii font font size style font size font font size style font size clarity section nbsp nbsp nbsp shall apply font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size during period following termination this agreement with respect terminated project neither nbsp breaching party subject section nbsp affiliate case termination pursuant section nbsp nbsp incyte subject section nbsp affiliate case termination incyte under section nbsp nbsp agenus under section nbsp nbsp agenus subject section nbsp affiliate case termination incyte pursuant section nbsp shall independently with third party develop each research manufacture commercialize field territory antibody that interacts with named target bullpen target which such terminated project directed product containing such antibody font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size termination this agreement shall addition shall prejudice party remedy equity including party ability receive legal damage equitable relief with respect breach this agreement regardless whether such breach reason termination font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size expiration termination this agreement reason shall release either party from obligation liability which effective date such expiration termination already accrued other party which attributable period prior such expiration termination font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size article viii nbsp section shall survive termination expiration this agreement font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp indemnification limitation liability font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold incyte font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size subject section nbsp nbsp incyte agrees incyte cost expense defend indemnify hold harmless agenus affiliate their respective director officer employee agent agenus indemnified party from against loss cost damage expense loss arising third party claim extent relating nbsp breach incyte representation warranty obligation pursuant this agreement nbsp negligence willful misconduct incyte nbsp except otherwise provided section nbsp development manufacture commercialization sale other disposition incyte incyte related party licensed antibody product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size event such claim against agenus indemnified party third party agenus shall promptly notify incyte writing claim subject section nbsp nbsp incyte shall have right exercisable notice agenus within after receipt notice from agenus claim assume direction control defense litigation settlement appeal other disposition claim including right settle claim solely monetary consideration with counsel selected incyte reasonably acceptable agenus nbsp agenus indemnified party shall cooperate with incyte font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size their option expense separately represented such action proceeding nbsp incyte shall liable litigation cost expense incurred agenus indemnified party without incyte prior written authorization addition nbsp incyte shall responsible indemnification defense agenus indemnified party extent arising from negligent intentional agenus indemnified party breach agenus representation obligation warranty under this agreement claim compromised settled without prior written consent notwithstanding foregoing nbsp incyte shall settle third party claim without prior written consent agenus such settlement would impose monetary obligation agenus require agenus submit injunction font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size notwithstanding anything contrary above event such claim against agenus indemnified party governmental criminal action seeking injunction against agenus agenus shall have right control defense litigation settlement appeal other disposition claim incyte expense font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size agenus font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size subject section nbsp agenus agrees agenus cost expense defend indemnify hold harmless incyte affiliate their respective director officer employee agent incyte indemnified party from against loss arising third party claim extent relating nbsp breach agenus representation warranty obligation pursuant this agreement nbsp claim that entry into this agreement grant license incyte hereunder violates oral written contractual obligation which agenus party which bound nbsp negligence willful misconduct agenus nbsp except otherwise provided section nbsp development manufacture commercialization sale other disposition agenus affiliate licensed antibody product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size event such claim against incyte indemnified party third party nbsp incyte shall promptly notify agenus writing claim subject section nbsp agenus shall have right exercisable notice incyte within after receipt notice from incyte claim assume direction control defense litigation settlement appeal other disposition claim including right settle claim solely monetary consideration with counsel selected agenus reasonably acceptable incyte incyte indemnified party shall cooperate with agenus their option expense separately represented such action proceeding nbsp agenus shall liable litigation cost expense incurred incyte indemnified party without agenus prior written authorization nbsp addition agenus shall responsible indemnification defense incyte indemnified party extent arising from negligent intentional incyte indemnified party breach incyte representation obligation warranty under this agreement claim compromised settled without prior written consent nbsp notwithstanding foregoing agenus shall settle third party claim without prior written consent incyte such settlement would impose monetary obligation incyte require incyte submit injunction font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size notwithstanding anything contrary above event such claim against incyte indemnified party governmental criminal action seeking injunction against incyte nbsp incyte shall have right control defense litigation settlement appeal other disposition claim agenus expense font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size shared claim loss arising third party claim involving actual alleged death bodily injury arising resulting from development manufacture commercialization profit share product field territory extent that such loss exceed amount covered applicable party product liability insurance excess product liability cost shall shared equally party product liability cost purpose calculating profit loss except extent such loss arise third party claim based nbsp party breach representation obligation warranty under this agreement nbsp negligence intentional party affiliate their respective permitted sublicensees respective officer director employee agent each foregoing entity performance obligation exercise right under this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size limitation liability nbsp except with respect breach article nbsp party liability pursuant article nbsp neither party shall liable special nbsp incidental consequential exemplary punitive multiple other indirect remote damage except with respect breach section nbsp loss profit loss data loss damage arising this agreement exercise right hereunder whether based upon warranty contract tort strict liability otherwise even such party been advised possibility such damage loss font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size joint several liability agenus shall jointly severally liable obligation agenus either agenus under this agreement font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp representation warranty covenant font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size representation authority consent nbsp agenus incyte each represents warrant covenant applicable other party that font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size execution date full right power authority enter into this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size execution date subject receipt clearance effective date this agreement been duly executed such party constitutes legal valid binding obligation such party enforceable accordance with term except enforceability limited bankruptcy fraudulent conveyance insolvency reorganization moratorium other relating affecting creditor right generally general equitable principle public policy constraint including those pertaining limitation font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size exclusion liability competition penalty jurisdictional issue including conflict font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size except clearance execution date except otherwise contemplated this agreement necessary consent approval authorization government authority other person required obtained such party connection with execution delivery performance this agreement have been shall obtained font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size neither affiliate been debarred subject debarment such party covenant that neither affiliate will capacity connection with development manufacture commercialization licensed antibody product field person been debarred pursuant section nbsp united state federal food drug cosmetic subject conviction described such section each party shall inform other party writing immediately upon learning that person performing service hereunder debarred subject conviction described section nbsp united state federal food drug cosmetic upon learning that action pending threatened relating debarment conviction such party affiliate person used capacity such party affiliate connection with development manufacture commercialization licensed antibody product field font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size conflict nbsp each party represents warrant other party that except otherwise disclosed other party writing execution delivery this agreement performance such party obligation hereunder nbsp conflict with violate such party corporate organizational document requirement applicable nbsp shall conflict with violate breach constitute default require consent under material oral written contractual obligation such party including case agenus under licr agreement nbsp each party agrees that shall during term this agreement grant right license consent privilege third party otherwise undertake action either directly indirectly that would conflict with right granted other party interfere with obligation such party forth this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size additional agenus representation warranty nbsp agenus represents warrant that execution date except previously disclosed incyte writing covenant applicable that font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size exhibit nbsp forth true complete list agenus patent right font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size agenus entitled grant right license sublicenses granted incyte pursuant section nbsp including pursuant licr agreement third party other than licr mskcc retains right under licr agreement that would preclude incyte from exercising right license granted this agreement except licr agreement there agreement arrangement which agenus affiliate font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size party relating licensed antibody agenus agenus platform that would limit right granted incyte under this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size agenus affiliate have have enforced after effective date during term shall have policy requiring their respective employee officer contractor consultant execute agreement requiring assignment agenus affiliate applicable invention made during course result their association with agenus such affiliate requiring each such employee officer contractor consultant maintain confidential confidential information receives during their performance their obligation agenus affiliate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size agenus knowledge third party nbsp infringing agenus patent right agenus platform patent right covering retrocyte display technology misappropriated agenus know agenus platform know nbsp challenged ownership scope duration validity enforceability priority right agenus patent right agenus platform patent right covering retrocyte display technology including through institution written threat institution interference post grant review inter partes review reexamination protest opposition nullity similar invalidity proceeding before patent trademark office analogous foreign entity agenus know agenus platform know font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size neither agenus affiliate granted after execution date during term neither agenus affiliate will grant right option license interest agenus patent right agenus know that conflict with right license granted incyte under this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size other than pursuant licr agreement accurate complete copy which been provided incyte nbsp none agenus agenus platform patent right covering retrocyte display technology agenus platform know been licensed sublicensed from third party nbsp there royalty other payment that would third party account development commercialization licensed antibody product hereunder result agreement entered into agenus affiliate before execution date font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size agenus default with respect material obligation under neither licr mskcc claimed that agenus knowledge agenus ground upon which claim that agenus default with respect material obligation under licr agreement except default that would have material adverse effect incyte program right hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size date that required maintain agenus patent right agenus platform patent right covering retrocyte display technology have been paid full agenus knowledge issued claim agenus patent right agenus platform patent right covering retrocyte display technology valid enforceable font style margin font size face time roman style font size font weight bold nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size neither agenus affiliate owns licensed under patent right know necessary develop manufacture commercialize product that included license granted hereunder incyte font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size neither agenus affiliate received written communication pending threatened claim against relating infringement intellectual property right third party mean practice agenus agenus platform patent right covering retrocyte display technology agenus platform know have them received written communication alleging that agenus affiliate violated through development manufacture import offering sale sale product containing agenus agenus platform patent right covering retrocyte display technology agenus platform know development manufacture commercialization licensed antibody product intellectual property right third party knowledge there reasonable basis such claim allegation font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size there legal claim judgment settlement against owed agenus affiliate order writ injunction decree governmental authority against agenus affiliate each case relating product agenus agenus platform patent right covering retrocyte display technology agenus platform know transaction contemplated this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size disclaimer warranty nbsp nothing this agreement shall construed representation made warranty given agenus that incyte will successful obtaining patent right that patent will issue based pending application that such pending application patent issued thereon will valid nbsp nothing this agreement shall construed representation made warranty given either party that will successful developing commercializing licensed antibody product nbsp except expressly forth this agreement patent right know licensed pursuant this agreement shall provided basis nbsp except expressly forth this agreement each party expressly disclaims waif release renounces warranty nbsp including implied warranty merchantability fitness particular purpose infringement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size standstill font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size incyte agrees that during initial discovery period unless specifically invited writing agenus nbsp incyte each affiliate will manner directly indirectly font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size effect seek offer propose effect whether publicly otherwise cause participate nbsp acquisition nbsp voting stock agenus security that such time convertible exchangeable into exercisable voting stock agenus collectively voting security font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size nbsp direct indirect right option acquire voting security nbsp asset security agenus subsidiary nbsp merger consolidation tender exchange offer other business combination involving agenus affiliate thereof nbsp restructuring recapitalization liquidation dissolution similar transaction with respect agenus affiliate thereof nbsp solicitation proxy such term defined used regulation under exchange consent with respect voting security election contest such term defined used rule nbsp exchange with respect agenus demand copy agenus stock ledger list stockholder other book record nbsp action inconsistent with term this section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size form join participate encourage formation group within meaning section nbsp nbsp exchange with respect voting security font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size otherwise alone concert with others including providing financing another party seek offer control influence manner management board director policy agenus font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size take action that might force agenus make public announcement regarding type matter forth section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size make publicly agenus director officer employee agent security holder directly indirectly request proposal amend waive terminate provision this section nbsp inquiry statement relating thereto font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size instigate encourage assist third party foregoing font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size notwithstanding foregoing provision this section nbsp restriction forth this section nbsp shall terminate further force effect nbsp agenus publicly engages process designed agenus solicit offer relating transaction which consummated would result change control agenus nbsp agenus enters into definitive agreement with respect publicly announces that plan enter into transaction involving controlling portion agenus voting security substantially agenus asset whether merger consolidation business combination tender exchange offer recapitalization restructuring sale equity issuance otherwise nbsp person group including incyte commences publicly announces intent commence tender exchange offer controlling portion agenus voting security font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size notwithstanding anything section nbsp contrary nbsp incyte affiliate acquire through that certain stock purchase agreement even date herewith font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size between agenus parent stock purchase agreement through open market purchase aggregate amount voting security that would represent than fifteen percent voting power represented agenus voting stock solely purpose investment ordinary course business long decision make such acquisition compliance with united state security nbsp nothing this section nbsp shall restrict passive investment employee benefit plan incyte affiliate long such investment directed independent trustee administrator employee have confidential information agenus font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size this section nbsp shall apply activity with respect licensed antibody product contemplated this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size additional covenant regarding licr agreement agenus agrees that during term font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size agenus shall commercially reasonable effort fulfill obligation under licr agreement extent that failure would materially adversely affect incyte right hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size agenus shall enter into subsequent agreement with other party licr agreement that modifies amends licr agreement that would materially adversely affect incyte right interest under this agreement without incyte prior written consent which shall unreasonably withheld delayed conditioned shall provide incyte with copy modification amendment licr agreement regardless whether incyte consent required with respect thereto font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size agenus shall terminate licr agreement whole part without incyte prior written consent such termination would materially adversely affect incyte right hereunder font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size agenus shall promptly furnish incyte with copy communication received agenus from other party licr agreement well material report other communication that agenus furnishes licr mskcc under licr agreement each case extent such communication report could reasonably affect right obligation incyte under this agreement agenus shall give incyte upon request reasonable opportunity review comment upon such report communication before they transmitted such other party agenus shall consider good faith reasonable comment timely provided incyte font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size agenus shall within five nbsp business after agenus receipt thereof furnish incyte with copy notice received agenus relating alleged breach default agenus under licr agreement that could materially adversely affect incyte agenus determines that chooses cure otherwise resolve such alleged breach default agenus shall notify incyte within five nbsp business such determination font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article nbsp confidentiality font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size confidential information font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size connection with performance their respective obligation under this agreement each party disclosing party itself through affiliate disclose certain confidential information other party recipient affiliate during term period thereafter recipient shall maintain confidential information disclosing party strict confidence shall such confidential information purpose except that recipient disclose permit disclosure such confidential information affiliate permitted sublicensees their respective director officer employee consultant advisor agent permitted subcontractor each case obligated maintain confidential nature such confidential information term stringent than those this article nbsp addition recipient disclose confidential information disclosing party nbsp exercising recipient right license granted hereunder including exercising these right discus with third party sublicensing opportunity fulfill obligation duty hereunder provided that such disclosure made person obligated confidentiality obligation rigorous than those this section nbsp nbsp subject section nbsp prosecuting defending litigation complying with applicable submitting information other governmental authority confidential information disclosing party includes confidential information defined prior confidentiality agreement which remains confidential information effective date this agreement disclosed disclosing party affiliate recipient affiliate pursuant prior confidentiality agreement font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size obligation confidentiality forth above shall apply extent that recipient demonstrate that relevant confidential information disclosing party nbsp publicly known prior time disclosure under this agreement other than through breach disclosing party affiliate prior confidentiality agreement nbsp became publicly known after time disclosure under this agreement other than through omission recipient affiliate potential sublicensees permitted sublicensees violation this agreement nbsp disclosed recipient affiliate time whether prior after time disclosure under this agreement prior confidentiality agreement third party having fiduciary relationship with disclosing party affiliate having obligation confidentiality with respect such confidential information nbsp independently developed recipient affiliate without access such confidential information evidenced written record nbsp known recipient affiliate time receipt from disclosing party affiliate documented recipient affiliate record font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size addition recipient affiliate disclose confidential information disclosing party extent necessary comply with applicable court administrative order provided that recipient provides disclosing party prior font style margin font size face time roman style font size font weight bold nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size written notice such disclosure extent reasonably possible that recipient take reasonable lawful action obtain confidential treatment such disclosure extent possible minimize extent such disclosure font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size notwithstanding obligation section nbsp nbsp party disclose connection therewith confidential information other party such disclosure font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size made governmental authority other regulatory authority order obtain patent right gain maintain approval nbsp conduct clinical trial with respect product provided hereunder nbsp market product provided hereunder such disclosure only extent reasonably necessary obtain such patent right authorization font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size made affiliate permitted sublicensees agent consultant other third party including service provider development manufacture commercialization licensed antibody product provided hereunder connection with assignment this agreement licensing transaction related product under this agreement loan financing investment acquisition merger consolidation similar transaction such person determine their interest performing such activity entering into such transaction each case condition that third party whom such disclosure made agree bound confidentiality obligation rigorous than those contained this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size consists entirely confidential information previously approved disclosing party disclosure recipient font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size each recipient shall responsible breach obligation this section nbsp person whom such recipient affiliate disclosed disclosing party confidential information font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size publicity attribution term this agreement name font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size party shall issue press release form attached exhibit nbsp within nbsp business after execution date announce execution this agreement describe material financial operational term this agreement except required judicial order applicable forth below neither party shall make public announcement concerning this agreement without prior written consent other party which consent shall unreasonably withheld delayed party preparing such public announcement shall provide other party with draft thereof least prior date which such party would like make public announcement neither party shall name trademark trade name logo other party employee licr publicity news release relating this agreement subject matter without prior express written permission other party applicable licr font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size notwithstanding term this article nbsp either party shall permitted disclose existence term this agreement extent required based advice such party legal counsel comply with applicable including rule nbsp regulation promulgated security exchange commission other governmental authority notwithstanding foregoing before disclosing this agreement term hereof pursuant this section nbsp party will consult with another term this agreement which confidential treatment will sought making such disclosure party wish disclose this agreement term hereof accordance with this section nbsp such party agrees expense seek confidential treatment portion this agreement such term reasonably requested other party provided that disclosing party shall always entitled comply with legal requirement including requirement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size either party also disclose existence term this agreement confidence attorney advisor potential acquirors their respective professional advisor connection with potential merger acquisition reorganization existing potential investor lender such party part their diligence investigation existing potential sublicensees permitted sublicensees assignee other person described section nbsp each case under agreement keep term this agreement confidential under term confidentiality substantially rigorous than term contained this agreement such information solely purpose permitted pursuant this section nbsp nbsp section nbsp font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size purpose clarity either party issue press release public announcement make such other disclosure content such press release public announcement disclosure previously been made public other than through breach this agreement issuing party affiliate font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size publication nbsp each party affiliate shall have right make disclosure pertaining licensed antibody product third party publication consistent with publication plan approved with prior approval accordance with following procedure nbsp publishing party shall provide publishing party with advance copy proposed publication other party shall then have prior submission publication which recommend change reasonably belief necessary preserve patent right know belonging whole part publishing party nbsp publishing party informs publishing party that such publication publishing party reasonable judgment could expected have material adverse effect patentable invention owned licensed whole part publishing party other than pursuant license granted under this agreement know which confidential information publishing party publishing party shall delay prevent such publication follows nbsp nbsp with respect patentable invention such publication shall delayed sufficiently long exceed sixty permit timely preparation filing patent application nbsp with respect know which confidential information such publishing party such know font style margin font size face time roman style font size font weight bold nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size shall deleted from publication nbsp notwithstanding foregoing party shall permitted disclose information site such clinicaltrials accordance with normal business practice font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size return confidential information nbsp subject section upon expiration termination this agreement upon request receiving party shall return disclosing party destroy confidential information received receiving party affiliate from disclosing party affiliate copy reproduction thereof nbsp addition receiving party affiliate shall destroy nbsp nbsp note report other document prepared receiving party which contain confidential information disclosing party nbsp confidential information disclosing party copy reproduction thereof which electronic form otherwise returned disclosing party nbsp nothing this section nbsp shall require alteration modification deletion destruction archival tape other electronic back medium made ordinary course business provided that receiving party affiliate shall continue bound obligation confidentiality other obligation under this article with respect disclosing party confidential information contained such archival tape other electronic back medium nbsp requested destruction disclosing party confidential information shall certified writing disclosing party authorized officer receiving party supervising such destruction nbsp notwithstanding foregoing nbsp receiving party affiliate retain copy disclosing party confidential information solely purpose determining receiving party continuing obligation under this article nbsp receiving party affiliate retain disclosing party confidential information note report other document extent reasonably required nbsp exercise right license receiving party expressly surviving expiration termination this agreement nbsp perform obligation receiving party expressly surviving expiration termination this agreement regulatory archival purpose nbsp notwithstanding return destruction disclosing party confidential information receiving party shall continue bound obligation confidentiality other obligation under this article font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article miscellaneous font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size governing nbsp this agreement claim dispute arising related thereto transaction contemplated thereby inducement party enter therein whether breach contract tortious conduct otherwise whether predicated common statute otherwise shall respect governed construed accordance with state york including matter construction validity performance each case without reference conflict rule nbsp that might lead application other jurisdiction font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size dispute resolution nbsp matter before project management team subcommittee shall governed process specified section nbsp nbsp controversy claim dispute arising relating this agreement that subject section nbsp shall settled possible through good faith negotiation between party nbsp party font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size unable settle such dispute within such dispute controversy claim arising relating this agreement breach termination invalidity thereof shall resolved follows font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size executive officer both party shall meet attempt resolve such dispute such resolution referred issue shall final binding party negotiation pursuant this section confidential shall treated compromise settlement negotiation purpose applicable rule evidence font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size executive officer resolve such dispute within after either party request such meeting writing such dispute relate scientific budgetary matter over which responsibility matter described section then font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size dispute relates whether milestone event been achieved whether incyte abandoned development abandoned commercialization product project inventorship patent right then matter will submitted expert resolution accordance with procedure forth schedule font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size other case either party seek resolution such dispute court competent jurisdiction font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size notwithstanding anything contrary this section either party sole judgment belief that such breach this agreement could cause irreparable harm such party will entitled seek equitable relief order avoid such irreparable harm will required follow procedure forth section with respect seeking such relief font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size assignment font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size neither party assign right obligation under this agreement without prior written consent other party except that either party make such assignment without prior written consent other party affiliate long such party shall remain jointly severally liable with such affiliate with respect obligation assigned forth section nbsp request consent assignment shall unreasonably withheld delayed nbsp purported assignment contravention this section nbsp shall option assigning party null void effect nbsp assignment shall release either party from responsibility performance accrued obligation such party hereunder nbsp this agreement shall binding upon enforceable against successor permitted assignee from either party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size each party agrees that notwithstanding provision this agreement contrary font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size either party assign this agreement along with right license granted hereunder obligation which subject hereunder third party connection with change control subject section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size event that this agreement assigned party connection with change control party otherwise undergoes change control nbsp other party shall entitled right access intellectual property right assignee acquirer such party nbsp assignee acquirer shall entitled right access intellectual property right other party shall bound provision section nbsp font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size entire agreement amendment nbsp this agreement exhibit referred this agreement constitute entire agreement between party with respect subject matter hereof supersede previous arrangement with respect subject matter hereof whether written oral including prior confidentiality agreement nbsp amendment modification this agreement shall made writing signed both party font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size notice nbsp communication notice instruction consent provided herein connection herewith shall made writing sent address below will given person sent registered certified mail return receipt requested postage prepaid nbsp sent reputable international overnight courier service such communication notice instruction consent will deemed have been delivered receipt given person three business after sent registered certified airmail return receipt requested postage prepaid within same country recipient address five business after sent registered certified airmail return receipt requested postage prepaid from another country business after sent reputable international overnight courier service font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size notice agenus shall addressed font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size agenus font style margin text indent font size face time roman style font size forbes road font style margin text indent font size face time roman style font size lexington massachusetts font style margin text indent font size face time roman style font size attention general counsel font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size with copy font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size choate hall stewart font style margin text indent font size face time roman style font size international place font style margin text indent font size face time roman style font size boston massachusetts font style margin text indent font size face time roman style font size attention gerald quirk font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size notice shall addressed font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size antibody font style margin text indent font size face time roman style font size hochbergerstrasse font style margin text indent font size face time roman style font size basel switzerland font style margin text indent font size face time roman style font size attention robert burn managing director font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size with copy font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size agenus font style margin text indent font size face time roman style font size forbes road font style margin text indent font size face time roman style font size lexington massachusetts font style margin text indent font size face time roman style font size attention general counsel font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size notice incyte shall addressed font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size incyte europe sarl font style margin text indent font size face time roman style font size incyte corporation font style margin text indent font size face time roman style font size augustine font style margin text indent font size face time roman style font size wilmington delaware font style margin text indent font size face time roman style font size attention general counsel font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size with copy font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size wilmerhale font style margin text indent font size face time roman style font size state street font style margin text indent font size face time roman style font size boston massachusetts font style margin text indent font size face time roman style font size attention steven singer font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font style italic provided font font size style font size however that either party will have designated different address notice other party accordance with this section then last address designated font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size force majeure nbsp failure omission either party performance obligation this agreement shall deemed breach this agreement create liability same shall arise from force majeure event provided that party affected such cause promptly notifies other party diligent effort cure such failure omission soon practicable after occurrence more above mentioned cause font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size compliance with nbsp each party shall perform obligation under this agreement compliance with applicable font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size name logo symbol nbsp subject section article party shall name trademark trade name physical likeness employee name owner symbol other party purpose including private public security placement without prior written consent affected party nbsp nothing contained this font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size agreement except section article shall construed granting either party right license other party trademark trade name name employee thereof without separate express written permission owner such trademark trade name name font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size independent contractor nbsp understood agreed that relationship between party that independent contractor that nothing this agreement shall construed create joint venture relationship employment agency partnership between party this agreement nbsp neither party authorized make representation commitment statement kind behalf other party take action that would bind other party nbsp furthermore none transaction contemplated this agreement shall construed partnership purpose font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size implied waiver right cumulative nbsp failure part agenus incyte exercise delay either party exercising right power remedy privilege under this agreement provided statute equity otherwise shall impair prejudice constitute waiver such right power remedy privilege such party construed waiver breach this agreement acquiescence therein such party shall single partial exercise such right power remedy privilege party preclude other further exercise thereof exercise other right power remedy privilege font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size severability nbsp under applicable provision this agreement invalid unenforceable otherwise directly indirectly affect validity other material provision nbsp this agreement such invalid unenforceable provision severed clause this agreement shall endure except severed clause nbsp party shall consult another good faith effort agree upon valid enforceable provision that reasonable substitute severed clause view intent this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size execution counterpart nbsp this agreement executed number counterpart each which shall deemed original which together shall constitute same instrument nbsp signature provided facsimile transmission adobe portable document format sent electronic mail shall deemed original signature font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size third party beneficiary nbsp person other than incyte agenus their respective successor permitted assignee shall deemed intended beneficiary hereunder have right enforce obligation this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size performance affiliate nbsp either party more affiliate perform obligation duty hereunder affiliate party expressly granted certain right herein provided that each such affiliate shall bound corresponding obligation such party party shall remain liable hereunder prompt payment performance their respective obligation hereunder font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size exhibit nbsp event inconsistency between this agreement exhibit hereto term this agreement shall control font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size parent guarantee parent hereby irrevocably unconditionally guarantee obligation liability incyte arising under this agreement including full timely performance thereof this guarantee payment performance collection release extinguishment incyte obligation liability other than accordance with term this agreement whether decree bankruptcy similar proceeding otherwise shall affect continuing validity enforceability this guarantee font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size construction nbsp construing this agreement unless expressly specified otherwise font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size reference article section exhibit article section exhibit this agreement font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size except where context otherwise requires either gender includes other gender singular includes plural vice versa font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size heading title convenience only affect interpretation this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size list example following word including shall interpreted without limitation generality preceding word font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size except where context otherwise requires word used inclusive sense font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size term hereof hereto hereby herein hereunder word similar import when used this agreement refer this agreement whole particular provision this agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size term extent phrase extent mean degree which subject other thing extends such phrase mean simply font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size except where context otherwise requires will mean shall font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size reference agreement instrument mean such agreement instrument from time time amended modified supplemented subject restriction such amendment supplement modification forth herein font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size reference person also successor heir permitted assigns font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size except business specified refers calendar font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size period time specified date from given business business event calculated exclusive that business font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size monthly mean calendar month basis font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size quarter quarterly mean calendar quarter basis font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size annual annually mean calendar year basis font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size year mean three hundred sixty five period unless calendar year specified font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size reference include amendment modification such rule regulation issued thereunder whether such amendment modification made issuance such rule regulation occurs before only with respect event development occurring action taken condition existing after date such amendment modification issuance after execution date only extent such amendment modification extent occurs after date hereof have retroactive effect font style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size reference dollar herein shall mean dollar font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size when referring notice review consultation with prior written consent agreement agenus such notice review consultation consent agreement shall only required agenus font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size reference agenus shall mean either both agenus context require font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size capitalized term defined herein reflecting different part speech than capitalized term which defined herein shall interpreted correlative manner font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size definition reference agreement instrument other document herein shall construed referring such agreement instrument other document from time time amended supplemented otherwise modified subject restriction such amendment supplement modification forth herein font font size style font size font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size each party represents that been represented legal counsel connection with this agreement acknowledges that participated drafting hereof nbsp interpreting applying term provision this agreement party agree that presumption will apply against party which drafted such term provision font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold article xiii font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size filing both party shall promptly file event within seven business after execution date filing with pursuant font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size cooperation font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size party shall commercially reasonable effort promptly obtain clearance consummation this agreement stock purchase agreement transaction contemplated hereby thereby shall keep each other apprised status communication with inquiry request additional information from shall comply promptly with such inquiry request provided however that neither party shall required consent divestiture other disposition asset including asset affiliate either party consent other structural conduct remedy each party affiliate shall have obligation contest settle administratively court ruling order other action third party respecting transaction contemplated this agreement stock purchase agreement font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size party shall instruct their respective counsel cooperate with each other commercially reasonable effort facilitate expedite identification resolution such issue consequently expiration applicable waiting period nbsp each party counsel will undertake keep each other appropriately informed communication from personnel reviewing antitrust authority confer with each other regarding appropriate contact with response personnel nbsp incyte shall responsible filing connection with filing font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size style font weight bold termination passage time nbsp notwithstanding other provision this agreement contrary either party terminate this agreement effective upon notice other party clearance date shall have occurred before date that after party make their respective filing pursuant section nbsp this agreement terminated pursuant this section then this agreement shall terminate entirety clarity prior confidentiality agreement shall remain full force effect notwithstanding termination this agreement pursuant this section font style margin text indent font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size signature page follows font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style margin font size face time roman style font size nbsp font style margin text indent font size face time roman style font size witness whereof party have executed this agreement execution date font style margin font size face time roman style font size nbsp font table border cellspacing cellpadding width style border collapse collapse width width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold incyte europe sarl font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size laurent chardonnet font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style border none padding width style margin font size face time roman style font size laurent chardonnet font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size managing officer font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size signed geneva switzerland january font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold incyte corporation font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size solely with respect section font width valign style padding width style margin font size face time roman style font size nbsp font width colspan valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size herve hoppenot font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style border none padding width style margin font size face time roman style font size herve hoppenot font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size president chief executive officer font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold agenus font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size garo armen font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style border none padding width style margin font size face time roman style font size garo armen font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size chairman chief executive officer font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width colspan valign style padding width style margin font size face time roman style font size font weight bold antibody font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size font weight bold nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size robert burn font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style border none padding width style margin font size face time roman style font size robert burn font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size managing director font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size font width valign style border none border bottom solid windowtext padding width style margin font size face time roman style font size marc dijk font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style border none padding width style margin font size face time roman style font size marc dijk font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size nbsp font width valign style padding width style margin font size face time roman style font size site head basel chief technology officer font table style margin text indent font size face time roman style font size font weight bold nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font style margin text indent font size face time roman style font size font weight bold nbsp font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit font align center style margin text align center font size face time roman style font size font weight bold agenus patent right font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font style margin font size face time roman style font size nbsp font style margin size width noshade color align left folio file task user clear style page break before always style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold exhibit nbsp font align center style margin text align center font size face time roman style font size font weight bold initial press release font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold attached font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font style margin font size face time roman style font size nbsp font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman width height font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold immediate release font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold incyte agenus announce global alliance develop novel immuno oncology antibody font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size font style italic alliance initially focus four checkpoint modulator program directed gitr font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size font style italic incyte have access agenus proprietary retrocyte display font font size style font size position relative font font size style font size font style italic platform discovery additional therapeutic antibody font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size font style italic agenus receive million comprised million technology program access under collaboration plus million equity investment agenus share font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size font style italic agenus eligible receive million development regulatory commercial milestone across four lead program font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size wilmington lexington january nbsp incyte corporation nasdaq incy agenus nasdaq agen today announced global license development commercialization agreement focused novel immuno therapeutic using agenus proprietary retrocyte display antibody discovery platform font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size alliance will initially focus development checkpoint modulator antibody directed against gitr agenus incyte will share cost profit gitr antibody program basis with agenus eligible potential milestone royalty bearing program funded incyte with agenus eligible potential milestone royalty first clinical trial expected initiated font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size this alliance with agenus therapeutic antibody capability proven small molecule discovery expertise significantly expands landscape potential immuno oncology target available strengthens ability identify advance novel therapeutic combination said herv hoppenot president incyte font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size incyte track record success oncology development commercialization together with therapeutic antibody expertise commonality objective speak compelling strategic rationale this alliance said garo armen chairman agenus retrocyte display font font size style font size position relative font font size style font size technology produced high quality antibody candidate offer significant advantage over competing technology with incyte believe have ideal partner help define evolving treatment paradigm cancer immunotherapy font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font style margin font size face time roman style font size nbsp font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size under term agreement between party nbsp incyte will make upfront payment agenus totaling million invest million purchasing approximately million newly issued share agenus common stock price share addition initial four target program alliance party have option jointly nominate pursue additional target within framework multi year collaboration term also include font style margin font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size each royalty bearing product agenus will eligible receive million future contingent development regulatory commercialization milestone font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size also royalty bearing product agenus will eligible receive tiered royalty global sale ranging from single double digit rate reserved right elect fund development cost increased royalty font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size product from additional program that party elect bring into collaboration agenus designate them profit share product font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face symbol style font size font font size style font size font font size style font size each profit share product agenus will eligible receive million future contingent development milestone font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size retrocyte display proprietary retroviral technology that enables highly diverse library font font size style font size position relative font font size style font size human molecule displayed surface lineage cell this innovative cell displayed expression platform permit rapid generation fully human humanized therapeutic antibody with high affinity target specificity font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size closing transaction conditioned expiration termination waiting period under hart scott rodino antitrust improvement font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold about incyte font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size incyte corporation wilmington delaware based biopharmaceutical company focused discovery development commercialization proprietary small molecule drug primarily oncology additional information incyte please visit company website incyte font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold about agenus font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size agenus immuno oncology company developing portfolio checkpoint modulators cpms heat shock protein peptide based vaccine adjuvant agenus checkpoint modulator program target gitr ctla company proprietary discovery engine retrocyte display font font size style font size position relative font font size style font size used generate fully human humanized therapeutic antibody drug candidate retrocyte display font font size style font size position relative font font size style font size platform high throughput approach incorporating format human antibody library expressed mammalian lineage cell agenus heat shock protein based vaccine cancer infectious disease have completed phase study glioblastoma multiforme treatment herpes simplex viral infection company stimulon font font size style font size position relative font font size style font size adjuvant platform extensively partnered with glaxosmithkline janssen science ireland includes several vaccine candidate phase well shingle malaria vaccine which have successfully completed phase clinical trial more information please visit agenusbio connect with company facebook linkedin twitter google font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold incyte forward looking statement font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size except historical information forth herein matter forth this press release including without limitation statement with respect initial focus alliance potential benefit alliance expectation that first clinical trial under alliance will initiated contain prediction estimate forward looking statement within meaning safe harbor provision private security litigation reform these forward looking statement based incyte current expectation subject risk uncertainty that cause actual result differ materially including high degree risk associated with drug development result further research development unanticipated delay other market economic factor technological advance regulatory approval transaction other risk detailed from time time incyte filing with security exchange commission including quarterly report form nbsp quarter ended september nbsp incyte disclaims intent obligation update these forward looking statement font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold agenus forward looking statement font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size this press release contains forward looking statement that made pursuant safe harbor provision federal security including statement regarding initial focus alliance between agenus incyte potential benefit alliance expectation that first clinical trial under alliance will initiated these forward looking statement subject risk uncertainty that could cause actual result differ materially from those projected these risk uncertainty include among others regulatory approval transaction unanticipated delay other market economic factor well factor described under risk factor section most recently filed quarterly report form nbsp with security exchange commission agenus caution investor place considerable reliance forward looking statement contained this release these statement speak only date this press release agenus undertakes obligation update revise statement other than extent required forward looking statement expressly qualified their entirety this cautionary statement font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold incyte contact font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size pamela murphy font style margin font size face time roman style font size vice president nbsp investor relation nbsp corporate communication font style margin font size face time roman style font size font style margin font size face time roman style font size font weight bold nbsp font style margin font size face time roman style font size font weight bold agenus contact font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size medium font style margin font size face time roman style font size brad mile communication font style margin font size face time roman style font size font style margin font size face time roman style font size bmiles bmccommunications font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size investor font style margin font size face time roman style font size andrea rabney argot partner font style margin font size face time roman style font size font style margin font size face time roman style font size andrea argotpartners font style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold schedule font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold schedule font align center style margin text align center font size face time roman style font size font weight bold preliminary action plan font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold attached font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size name font style margin size width noshade color align left folio file task user clear style page break before always align center style margin text align center font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold schedule font align center style margin text align center font size face time roman style font size font weight bold allocation license font align center style margin text align center font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold font style margin font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font style margin size width noshade color align left folio file task user clear style page break before always style font family time roman style margin font size face time roman style font size nbsp font align center style margin text align center font size face time roman style font size font weight bold schedule font align center style margin text align center font size face time roman style font size font weight bold expert decision font align center style margin text align center font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold selection expert submission position font font size style font size font weight bold font font size style font size party shall select agree upon mutually acceptable independent third party expert neutral disinterested impartial experience relevant evaluation biotechnology industry collaboration agreement expert party unable mutually agree upon expert within font font size style font size font weight bold font font size style font size following initiation these expert decision procedure then upon request either party expert shall arbitrator appointed judicial mediation service once expert been selected each party shall within font font size style font size font weight bold font font size style font size following selection expert provide expert other party with written report setting forth position with respect substance dispute submit revised updated report position expert within font font size style font size font weight bold font font size style font size receiving other party report requested expert each party shall make oral submission expert based such party written report each party shall have right present during such oral submission font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold supervision font font size style font size font weight bold font font size style font size event expert arbitrator selected provided this schedule matter shall conducted binding arbitration accordance with procedure modified this schedule including that arbitrator shall adopt decision position party other described below such event arbitrator retain third party expert with experience relevant evaluation biotechnology industry collaboration agreement assist rendering such decision expense such expert shall shared party cost arbitration provided this schedule font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold determination expert font font size style font size font weight bold font font size style font size expert shall later than font font size style font size font weight bold font font size style font size after last submission written report oral submission select party position final decision shall have authority modify either party position render substantive decision other than select position either party forth their respective written report initially submitted revised accordance with this schedule applicable party agree that decision expert shall sole exclusive binding remedy between them regarding such dispute referred expert pursuant section nbsp this agreement expert decision shall become decision party applicable matter font style margin text indent font size face time roman style font size nbsp font style margin text indent font size face time roman style font size font font size style font size font font size style font size font weight bold location cost font font size style font size font weight bold font font size style font size unless otherwise mutually agreed upon party person portion such proceeding shall conducted york york party agree that they shall share equally cost expert connection with proceeding under this schedule including cost arbitration filing hearing cost independent expert retained arbitrator cost arbitrator administrative applicable each party shall bear cost attorney witness associated cost expense incurred connection with proceeding under this schedule font style margin text indent font size face time roman style font size nbsp font style margin font size face time roman style font size font weight bold portion this exhibit have been omitted pursuant confidential treatment request unredacted version this exhibit been filed separately with commission font align center style margin text align center font size face time roman style font size nbsp font style margin size width noshade color align left folio file task user body html text document